{ "instance": { "form20f.htm": { "axisCustom": 5, "axisStandard": 11, "contextCount": 184, "dts": { "calculationLink": { "local": [ "pmedf-20220131_cal.xml" ] }, "definitionLink": { "local": [ "pmedf-20220131_def.xml" ] }, "inline": { "local": [ "form20f.htm" ] }, "labelLink": { "local": [ "pmedf-20220131_lab.xml" ] }, "presentationLink": { "local": [ "pmedf-20220131_pre.xml" ] }, "schema": { "local": [ "pmedf-20220131.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 451, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 7, "total": 7 }, "keyCustom": 79, "keyStandard": 202, "memberCustom": 36, "memberStandard": 19, "nsprefix": "pmedf", "nsuri": "http://predictmedix.com/20220131", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "span", "strong", "span", "p", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001 - Document - Document And Entity Information", "role": "http://predictmedix.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "strong", "span", "p", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0010 - Disclosure - Sale of interest in Cultivar JA Limited", "role": "http://predictmedix.com/role/SaleOfInterestInCultivarJALimited", "shortName": "Sale of interest in Cultivar JA Limited", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "pmedf:DisclosureOfPrepaidExpensesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0011 - Disclosure - Prepaid Expenses", "role": "http://predictmedix.com/role/PrepaidExpenses", "shortName": "Prepaid Expenses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "pmedf:DisclosureOfPrepaidExpensesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0012 - Disclosure - Property and Equipment", "role": "http://predictmedix.com/role/PropertyAndEquipment", "shortName": "Property and Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0013 - Disclosure - Intangible Assets", "role": "http://predictmedix.com/role/IntangibleAssets", "shortName": "Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0014 - Disclosure - Leases", "role": "http://predictmedix.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0015 - Disclosure - Stock-based Compensation", "role": "http://predictmedix.com/role/StockbasedCompensation", "shortName": "Stock-based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0016 - Disclosure - Capital Stock", "role": "http://predictmedix.com/role/CapitalStock", "shortName": "Capital Stock", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0017 - Disclosure - Related Party Transactions", "role": "http://predictmedix.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0018 - Disclosure - Commitments and Contingencies", "role": "http://predictmedix.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0019 - Disclosure - Financial Instruments", "role": "http://predictmedix.com/role/FinancialInstruments", "shortName": "Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "span", "strong", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:CashAndCashEquivalents", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0002 - Statement - Consolidated Statements of Financial Position", "role": "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition", "shortName": "Consolidated Statements of Financial Position", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "strong", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131", "decimals": "0", "lang": null, "name": "ifrs-full:CurrentTradeReceivables", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0020 - Disclosure - Capital Management", "role": "http://predictmedix.com/role/CapitalManagement", "shortName": "Capital Management", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0021 - Disclosure - Business Segment and Concentration", "role": "http://predictmedix.com/role/BusinessSegmentAndConcentration", "shortName": "Business Segment and Concentration", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0022 - Disclosure - Income Taxes", "role": "http://predictmedix.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0023 - Disclosure - Significant Accounting Policies (Policies)", "role": "http://predictmedix.com/role/SignificantAccountingPoliciesPolicies", "shortName": "Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0024 - Disclosure - Acquisitions (Tables)", "role": "http://predictmedix.com/role/AcquisitionsTables", "shortName": "Acquisitions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0025 - Disclosure - Sale of interest in Cultivar JA Limited (Tables)", "role": "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedTables", "shortName": "Sale of interest in Cultivar JA Limited (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0026 - Disclosure - Property and Equipment (Tables)", "role": "http://predictmedix.com/role/PropertyAndEquipmentTables", "shortName": "Property and Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "pmedf:DisclosureOfDetailedInformationAboutPurchasePriceAllocationOfIntangibleAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0027 - Disclosure - Intangible Assets (Tables)", "role": "http://predictmedix.com/role/IntangibleAssetsTables", "shortName": "Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "pmedf:DisclosureOfDetailedInformationAboutPurchasePriceAllocationOfIntangibleAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0028 - Disclosure - Leases (Tables)", "role": "http://predictmedix.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0029 - Disclosure - Stock-based Compensation (Tables)", "role": "http://predictmedix.com/role/StockbasedCompensationTables", "shortName": "Stock-based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "strong", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0003 - Statement - Consolidated Statements of Loss and Comprehensive Loss", "role": "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "shortName": "Consolidated Statements of Loss and Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "strong", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0030 - Disclosure - Capital Stock (Tables)", "role": "http://predictmedix.com/role/CapitalStockTables", "shortName": "Capital Stock (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0031 - Disclosure - Related Party Transactions (Tables)", "role": "http://predictmedix.com/role/RelatedPartyTransactionsTables", "shortName": "Related Party Transactions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "div", "div", "div", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "pmedf:DisclosureOfDetailedInformationAboutReconciliationOfProvisionForIncomeTaxesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0032 - Disclosure - Income Taxes (Tables)", "role": "http://predictmedix.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "pmedf:DisclosureOfDetailedInformationAboutReconciliationOfProvisionForIncomeTaxesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "span", "p", "div", "pmedf:DisclosureOfOrganizationAndNatureOfOperationsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20190923_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0033 - Disclosure - Organization and Nature of Operations (Narrative) (Details)", "role": "http://predictmedix.com/role/OrganizationAndNatureOfOperationsDetailTextuals", "shortName": "Organization and Nature of Operations (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "div", "pmedf:DisclosureOfOrganizationAndNatureOfOperationsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20190923_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "span", "strong", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:CashAndCashEquivalents", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0034 - Disclosure - Basis of Presentation and Going Concern (Narrative) (Details)", "role": "http://predictmedix.com/role/BasisOfPresentationAndGoingConcernDetails", "shortName": "Basis of Presentation and Going Concern (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "div", "pmedf:DisclosureOfBasisOfPresentationAndGoingConcernExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131", "decimals": "0", "lang": null, "name": "pmedf:WorkingCapital", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "div", "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "div", "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember", "decimals": "2", "first": true, "lang": null, "name": "ifrs-full:DepreciationRatePropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "Percent", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0035 - Disclosure - Significant Accounting Policies (Narrative) (Details)", "role": "http://predictmedix.com/role/SignificantAccountingPoliciesDetailTextuals", "shortName": "Significant Accounting Policies (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "div", "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "div", "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember", "decimals": "2", "first": true, "lang": null, "name": "ifrs-full:DepreciationRatePropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "Percent", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "span", "p", "div", "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20200131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0036 - Disclosure - Acquisitions (Narrative) (Details)", "role": "http://predictmedix.com/role/AcquisitionsDetailTextuals", "shortName": "Acquisitions (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "div", "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20200131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory", "div", "div", "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20200131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0037 - Disclosure - Acquisitions (Disclosure of fair value of the acquired assets and liabilities assumed) (Details)", "role": "http://predictmedix.com/role/AcquisitionsDetails", "shortName": "Acquisitions (Disclosure of fair value of the acquired assets and liabilities assumed) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory", "div", "div", "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20200131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20200201to20210131", "decimals": "INF", "first": true, "lang": null, "name": "pmedf:IncreaseDecreaseThroughDisposalOfSubsidiaryShares", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0038 - Disclosure - Sale of interest in Cultivar JA Limited (Narrative) (Details)", "role": "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedDetailTextuals", "shortName": "Sale of interest in Cultivar JA Limited (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "div", "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20200327to20200327_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember", "decimals": "INF", "lang": null, "name": "pmedf:IncreaseDecreaseThroughDisposalOfSubsidiaryShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "span", "strong", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:AmortisationExpense", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0039 - Disclosure - Sale of interest in Cultivar JA Limited (Disclosure of Income (loss) from discontinued operations) (Details)", "role": "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedDetails", "shortName": "Sale of interest in Cultivar JA Limited (Disclosure of Income (loss) from discontinued operations) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory", "div", "div", "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember", "decimals": "0", "lang": null, "name": "ifrs-full:AmortisationExpense", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20200131_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Equity", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0004 - Statement - Consolidated Statement Of Changes In Shareholders' Equity", "role": "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity", "shortName": "Consolidated Statement Of Changes In Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20200131_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Equity", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "span", "strong", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:CurrentPrepaidExpenses", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0040 - Disclosure - Prepaid Expenses (Narrative) (Details)", "role": "http://predictmedix.com/role/PrepaidExpensesDetailTextuals", "shortName": "Prepaid Expenses (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "span", "p", "div", "pmedf:DisclosureOfPrepaidExpensesExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfStudyOnDetectionTechnologyMember", "decimals": "0", "lang": null, "name": "ifrs-full:CurrentPrepaidExpenses", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:PropertyPlantAndEquipment", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0041 - Disclosure - Property and Equipment (Disclosure of property and equipment) (Details)", "role": "http://predictmedix.com/role/PropertyAndEquipmentDetails", "shortName": "Property and Equipment (Disclosure of property and equipment) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "strong", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "div", "div", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember", "decimals": "0", "lang": null, "name": "ifrs-full:PropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0042 - Disclosure - Intangible Assets (Narrative) (Details)", "role": "http://predictmedix.com/role/IntangibleAssetsDetailTextuals", "shortName": "Intangible Assets (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "div", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20200701to20200721_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember", "decimals": "INF", "lang": null, "name": "pmedf:SharesIssuedToAcquireIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0043 - Disclosure - Intangible Assets (Disclosure of detailed information about purchase price allocation of intangible assets) (Details)", "role": "http://predictmedix.com/role/IntangibleAssetsDetails", "shortName": "Intangible Assets (Disclosure of detailed information about purchase price allocation of intangible assets) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "pmedf:DisclosureOfDetailedInformationAboutPurchasePriceAllocationOfIntangibleAssetsExplanatory", "div", "div", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20200701to20200721_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember", "decimals": "0", "lang": null, "name": "pmedf:ValueOfSharesIssuedToAcquireIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0044 - Disclosure - Intangible Assets (Disclosure of detailed information about intangible assets) (Details)", "role": "http://predictmedix.com/role/IntangibleAssetsDetails1", "shortName": "Intangible Assets (Disclosure of detailed information about intangible assets) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "strong", "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "div", "div", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember", "decimals": "0", "lang": null, "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "span", "span", "span", "p", "div", "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:RightofuseAssets", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0045 - Disclosure - Leases (Narrative) (Details)", "role": "http://predictmedix.com/role/LeasesDetailTextuals", "shortName": "Leases (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "span", "p", "div", "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:RightofuseAssets", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "strong", "td", "tr", "table", "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "div", "div", "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20200131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:RightofuseAssets", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0046 - Disclosure - Leases (Disclosure of right of use assets) (Details)", "role": "http://predictmedix.com/role/LeasesDetails", "shortName": "Leases (Disclosure of right of use assets) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "strong", "td", "tr", "table", "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "div", "div", "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20200201to20210131", "decimals": "0", "lang": null, "name": "ifrs-full:DepreciationRightofuseAssets", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "span", "span", "p", "div", "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:LeaseLiabilities", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0047 - Disclosure - Leases (Disclosure of lease liability interest expense recognized) (Details)", "role": "http://predictmedix.com/role/LeasesDetails1", "shortName": "Leases (Disclosure of lease liability interest expense recognized) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "strong", "td", "tr", "table", "ifrs-full:DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory", "div", "div", "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20200201to20210131", "decimals": "0", "lang": null, "name": "ifrs-full:InterestExpenseOnLeaseLiabilities", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "pmedf:DisclosureOfDetailedInformationAboutLeaseLiabilityExplanatory", "div", "div", "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:CurrentLeaseLiabilities", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0048 - Disclosure - Leases (Disclosure of lease liability) (Details)", "role": "http://predictmedix.com/role/LeasesDetails2", "shortName": "Leases (Disclosure of lease liability) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "pmedf:DisclosureOfDetailedInformationAboutLeaseLiabilityExplanatory", "div", "div", "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:CurrentLeaseLiabilities", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "span", "span", "span", "span", "span", "p", "div", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": "2", "first": true, "lang": null, "name": "pmedf:OptionsAuthorizedUnderStockOptionPlanAsPercentageOfIssuedAndOutstandingCommonShares", "reportCount": 1, "unique": true, "unitRef": "Percent", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0049 - Disclosure - Stock-based Compensation (Narrative) (Details)", "role": "http://predictmedix.com/role/StockbasedCompensationDetailTextuals", "shortName": "Stock-based Compensation (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "span", "span", "span", "p", "div", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": "2", "first": true, "lang": null, "name": "pmedf:OptionsAuthorizedUnderStockOptionPlanAsPercentageOfIssuedAndOutstandingCommonShares", "reportCount": 1, "unique": true, "unitRef": "Percent", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "span", "strong", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:ProfitLoss", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0005 - Statement - Consolidated Statements of Cash Flows", "role": "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": "0", "lang": null, "name": "ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "span", "span", "span", "span", "span", "p", "div", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": "0", "first": true, "lang": null, "name": "pmedf:UnvestedStockBasedCompensationExpense", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0050 - Disclosure - Stock-based Compensation (Disclosure of detailed information about options, valuation assumptions) (Details)", "role": "http://predictmedix.com/role/StockbasedCompensationDetails", "shortName": "Stock-based Compensation (Disclosure of detailed information about options, valuation assumptions) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "span", "span", "span", "td", "tr", "table", "div", "pmedf:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory", "div", "div", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember", "decimals": "4", "lang": null, "name": "ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted", "reportCount": 1, "unique": true, "unitRef": "Percent", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "span", "span", "span", "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "div", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210131", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfOutstandingShareOptions", "reportCount": 1, "unitRef": "Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0051 - Disclosure - Stock-based Compensation (Disclosure of number and weighted average exercise prices of share options) (Details)", "role": "http://predictmedix.com/role/StockbasedCompensationDetails1", "shortName": "Stock-based Compensation (Disclosure of number and weighted average exercise prices of share options) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "span", "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "div", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": "INF", "lang": null, "name": "ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "span", "span", "span", "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "div", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfOutstandingShareOptions", "reportCount": 1, "unitRef": "Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0052 - Disclosure - Stock-based Compensation (Disclosure of number and weighted average remaining contractual life of outstanding share options) (Details)", "role": "http://predictmedix.com/role/StockbasedCompensationDetails2", "shortName": "Stock-based Compensation (Disclosure of number and weighted average remaining contractual life of outstanding share options) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "div", "ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory", "div", "div", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131", "decimals": "INF", "lang": null, "name": "ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "ifrs-full:NumberOfSharesOutstanding", "span", "span", "span", "span", "span", "span", "p", "div", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0053 - Disclosure - Capital Stock (Narrative) (Details)", "role": "http://predictmedix.com/role/CapitalStockDetailTextuals", "shortName": "Capital Stock (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ifrs-full:NumberOfSharesOutstanding", "span", "span", "span", "span", "span", "span", "p", "div", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "span", "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "div", "div", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210131", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "reportCount": 1, "unitRef": "Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0054 - Disclosure - Capital Stock (Disclosure of continuity of warrants) (Details)", "role": "http://predictmedix.com/role/CapitalStockDetails", "shortName": "Capital Stock (Disclosure of continuity of warrants) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "div", "div", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": "INF", "lang": null, "name": "ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "span", "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "div", "div", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "reportCount": 1, "unitRef": "Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0055 - Disclosure - Capital Stock (Disclosure of number, exercise price and remaining life of outstanding warrants) (Details)", "role": "http://predictmedix.com/role/CapitalStockDetails1", "shortName": "Capital Stock (Disclosure of number, exercise price and remaining life of outstanding warrants) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "span", "td", "tr", "table", "pmedf:DisclosureOfNumberExercisePriceAndRemainingContractualLifeOfOutstandingWarrantsExplanatory", "div", "div", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "lang": "en-US", "name": "pmedf:WeightedAverageRemainingContractualLifeOfOutstandingWarrants", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "span", "strong", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:SalesAndMarketingExpense", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0056 - Disclosure - Related Party Transactions (Narrative) (Details)", "role": "http://predictmedix.com/role/RelatedPartyTransactionsDetailTextuals", "shortName": "Related Party Transactions (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "span", "p", "div", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131", "decimals": "0", "lang": null, "name": "ifrs-full:AmountsPayableRelatedPartyTransactions", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "div", "div", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": "0", "first": true, "lang": null, "name": "pmedf:ManagementFees", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0057 - Disclosure - Related Party Transactions (Disclosure of transactions with key management personnel ) (Details)", "role": "http://predictmedix.com/role/RelatedPartyTransactionsDetails", "shortName": "Related Party Transactions (Disclosure of transactions with key management personnel ) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "div", "div", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": "0", "first": true, "lang": null, "name": "pmedf:ManagementFees", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "span", "p", "div", "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20200731_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember", "decimals": "0", "first": true, "lang": null, "name": "pmedf:MonthlyCompensation", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0058 - Disclosure - Commitments and Contingencies (Narrative) (Details)", "role": "http://predictmedix.com/role/CommitmentsAndContingenciesDetailTextuals", "shortName": "Commitments and Contingencies (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "div", "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20200731_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember", "decimals": "0", "first": true, "lang": null, "name": "pmedf:MonthlyCompensation", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "span", "strong", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:CashAndCashEquivalents", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0059 - Disclosure - Financial Instruments (Narrative) (Details)", "role": "http://predictmedix.com/role/FinancialInstrumentsDetailTextuals", "shortName": "Financial Instruments (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "div", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember", "decimals": "0", "lang": null, "name": "ifrs-full:CashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "pmedf:DisclosureOfOrganizationAndNatureOfOperationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0006 - Disclosure - Organization and Nature of Operations", "role": "http://predictmedix.com/role/OrganizationAndNatureOfOperations", "shortName": "Organization and Nature of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "pmedf:DisclosureOfOrganizationAndNatureOfOperationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "span", "strong", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Equity", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0060 - Disclosure - Capital Management (Narrative) (Details)", "role": "http://predictmedix.com/role/CapitalManagementDetailTextuals", "shortName": "Capital Management (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R61": { "firstAnchor": { "ancestors": [ "span", "span", "strong", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:PropertyPlantAndEquipment", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0061 - Disclosure - Business Segment and Concentration (Narrative) (Details)", "role": "http://predictmedix.com/role/BusinessSegmentAndConcentrationDetailTextuals", "shortName": "Business Segment and Concentration (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131_srtStatementGeographicalAxis_countryIN", "decimals": "0", "lang": null, "name": "ifrs-full:PropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "span", "span", "span", "td", "tr", "table", "pmedf:DisclosureOfDetailedInformationAboutReconciliationOfProvisionForIncomeTaxesExplanatory", "div", "div", "div", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:AccountingProfit", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0062 - Disclosure - Income Taxes - Disclosure of detailed information about effective income tax expense (recovery) (Details)", "role": "http://predictmedix.com/role/IncomeTaxesDetails", "shortName": "Income Taxes - Disclosure of detailed information about effective income tax expense (recovery) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "span", "td", "tr", "table", "pmedf:DisclosureOfDetailedInformationAboutReconciliationOfProvisionForIncomeTaxesExplanatory", "div", "div", "div", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:AccountingProfit", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "span", "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfDeferredTaxesExplanatory", "div", "div", "div", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:DeferredTaxAssets", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0063 - Disclosure - Income Taxes - Disclosure of detailed information about deferred tax assets (Details)", "role": "http://predictmedix.com/role/IncomeTaxesDetails1", "shortName": "Income Taxes - Disclosure of detailed information about deferred tax assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfDeferredTaxesExplanatory", "div", "div", "div", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:DeferredTaxAssets", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "span", "span", "span", "td", "tr", "table", "pmedf:DisclosureOfDetailedInformationAboutUnrecognizedTemporaryDifferencesAndTaxLossesExplanatory", "div", "div", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfNonCapitalLossesAvailableForFuturePeriodMember", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0064 - Disclosure - Income Taxes - Disclosure of detailed information about unrecognized temporary differences and tax losses (Details)", "role": "http://predictmedix.com/role/IncomeTaxesDetails2", "shortName": "Income Taxes - Disclosure of detailed information about unrecognized temporary differences and tax losses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "span", "td", "tr", "table", "pmedf:DisclosureOfDetailedInformationAboutUnrecognizedTemporaryDifferencesAndTaxLossesExplanatory", "div", "div", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfNonCapitalLossesAvailableForFuturePeriodMember", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "pmedf:DisclosureOfBasisOfPresentationAndGoingConcernExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0007 - Disclosure - Basis of Presentation and Going Concern", "role": "http://predictmedix.com/role/BasisOfPresentationAndGoingConcern", "shortName": "Basis of Presentation and Going Concern", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "pmedf:DisclosureOfBasisOfPresentationAndGoingConcernExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0008 - Disclosure - Significant Accounting Policies", "role": "http://predictmedix.com/role/SignificantAccountingPolicies", "shortName": "Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0009 - Disclosure - Acquisitions", "role": "http://predictmedix.com/role/Acquisitions", "shortName": "Acquisitions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210201to20220131", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 58, "tag": { "country_IN": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INDIA", "terseLabel": "India [Member]" } } }, "localname": "IN", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://predictmedix.com/role/BusinessSegmentAndConcentrationDetailTextuals" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r191", "r192", "r193" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r191", "r192", "r193" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r191", "r192", "r193" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_ContactPersonnelName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of contact personnel", "label": "Contact Personnel Name" } } }, "localname": "ContactPersonnelName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r191", "r192", "r193" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r187" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r194" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityAddressesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Addresses [Line Items]" } } }, "localname": "EntityAddressesLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityAddressesTable": { "auth_ref": [ "r189" ], "lang": { "en-us": { "role": { "documentation": "Container of address information for the entity", "label": "Entity Addresses [Table]" } } }, "localname": "EntityAddressesTable", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r189" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r189" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r197" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r189" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r195" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityListingsExchangeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity Listings, Exchange [Axis]" } } }, "localname": "EntityListingsExchangeAxis", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r189" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r189" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r196" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well Known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_ExchangeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383.", "label": "Exchange [Domain]" } } }, "localname": "ExchangeDomain", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r191", "r192", "r193" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r188" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "ifrs-full_AccountingProfit": { "auth_ref": [ "r39", "r40" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Accounting profit", "verboseLabel": "Loss for the period" } } }, "localname": "AccountingProfit", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember": { "auth_ref": [ "r48", "r55", "r76", "r84", "r87" ], "lang": { "en": { "role": { "documentation": "This member stands for accumulated depreciation, amortisation and impairment. [Refer: Impairment loss; Depreciation and amortisation expense]" } }, "en-us": { "role": { "label": "Accumulated depreciation, amortisation and impairment [member]", "terseLabel": "Accumulated Amortization [Member]" } } }, "localname": "AccumulatedDepreciationAmortisationAndImpairmentMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_AccumulatedDepreciationAndAmortisationMember": { "auth_ref": [ "r48", "r55", "r76", "r84", "r87" ], "lang": { "en": { "role": { "documentation": "This member stands for accumulated depreciation and amortisation. [Refer: Depreciation and amortisation expense]" } }, "en-us": { "role": { "label": "Accumulated depreciation and amortisation [member]", "verboseLabel": "Accumulated amortization [Member]" } } }, "localname": "AccumulatedDepreciationAndAmortisationMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": { "auth_ref": [ "r142" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Consideration transferred, acquisition-date fair value", "negatedTerseLabel": "Fair value of shares issued", "terseLabel": "Fair value of shares issued", "verboseLabel": "Total consideration" } } }, "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/AcquisitionsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r77" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase in intangible assets other than goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Acquisitions through business combinations, intangible assets other than goodwill", "positiveTerseLabel": "Acquisition", "terseLabel": "Cash consideration on closing", "verboseLabel": "Purchase price in cash" } } }, "localname": "AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r77" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Additions other than through business combinations, intangible assets other than goodwill", "positiveTerseLabel": "Additions", "terseLabel": "Total Consideration", "verboseLabel": "Asset acquisition for total consideration" } } }, "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": { "auth_ref": [ "r49" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]" } }, "en-us": { "role": { "label": "Additions other than through business combinations, property, plant and equipment", "terseLabel": "Additions" } } }, "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses": { "auth_ref": [ "r96" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows": { "order": 80.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for the decrease (increase) in prepaid expenses to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Current prepaid expenses; Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for decrease (increase) in prepaid expenses", "terseLabel": "Prepaid expenses" } } }, "localname": "AdjustmentsForDecreaseIncreaseInPrepaidExpenses", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": { "auth_ref": [ "r94" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows": { "order": 100.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for decrease (increase) in trade accounts receivable", "terseLabel": "Accounts receivable" } } }, "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": { "auth_ref": [ "r95" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows": { "order": 60.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for depreciation and amortisation expense", "terseLabel": "Amortization" } } }, "localname": "AdjustmentsForDepreciationAndAmortisationExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities": { "auth_ref": [ "r94" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows": { "order": 30.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for the increase (decrease) in deferred income other than contract liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred income other than contract liabilities; Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for increase (decrease) in deferred income other than contract liabilities", "negatedLabel": "Deferred revenue", "verboseLabel": "Deferred revenue" } } }, "localname": "AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": { "auth_ref": [ "r94" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows": { "order": 90.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for increase (decrease) in trade accounts payable", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile profit (loss) [abstract]", "verboseLabel": "Non-cash items included in net loss and other adjustments:" } } }, "localname": "AdjustmentsForReconcileProfitLossAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_AdjustmentsForSharebasedPayments": { "auth_ref": [ "r95" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows": { "order": 70.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for share-based payments", "terseLabel": "Share-based compensation" } } }, "localname": "AdjustmentsForSharebasedPayments", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdministrativeExpense": { "auth_ref": [ "r2", "r36", "r64" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 90.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expenses that the entity classifies as being administrative." } }, "en-us": { "role": { "label": "Administrative expenses", "terseLabel": "Management fees" } } }, "localname": "AdministrativeExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AmortisationExpense": { "auth_ref": [ "r8" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 80.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of amortisation expense. Amortisation is the systematic allocation of depreciable amounts of intangible assets over their useful lives." } }, "en-us": { "role": { "label": "Amortisation expense", "terseLabel": "Amortization" } } }, "localname": "AmortisationExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r78" ], "lang": { "en": { "role": { "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Amortisation, intangible assets other than goodwill", "verboseLabel": "Amortization" } } }, "localname": "AmortisationIntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r75" ], "lang": { "en": { "role": { "documentation": "The amortisation method used for intangible assets other than goodwill with finite useful lives. [Refer: Intangible assets other than goodwill; Depreciation and amortisation expense]" } }, "en-us": { "role": { "label": "Amortisation method, intangible assets other than goodwill", "verboseLabel": "Amortization method" } } }, "localname": "AmortisationMethodIntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetailTextuals" ], "xbrltype": "stringItemType" }, "ifrs-full_AmountsPayableRelatedPartyTransactions": { "auth_ref": [ "r59", "r62" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amounts payable resulting from related party transactions. [Refer: Related parties [member]]" } }, "en-us": { "role": { "label": "Amounts payable, related party transactions", "terseLabel": "Due to related parties" } } }, "localname": "AmountsPayableRelatedPartyTransactions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/RelatedPartyTransactionsDetailTextuals" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AmountsReceivableRelatedPartyTransactions": { "auth_ref": [ "r59", "r62" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amounts receivable resulting from related party transactions. [Refer: Related parties [member]]" } }, "en-us": { "role": { "label": "Amounts receivable, related party transactions", "verboseLabel": "Advanced to CEO" } } }, "localname": "AmountsReceivableRelatedPartyTransactions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/RelatedPartyTransactionsDetailTextuals" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ApplicableTaxRate": { "auth_ref": [ "r40" ], "lang": { "en": { "role": { "documentation": "The applicable income tax rate." } }, "en-us": { "role": { "label": "Applicable tax rate", "verboseLabel": "Tax rate" } } }, "localname": "ApplicableTaxRate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_Assets": { "auth_ref": [ "r17", "r117", "r118", "r119", "r169", "r172" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } }, "en-us": { "role": { "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [abstract]", "verboseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_AuditorsRemunerationForAuditServices": { "auth_ref": [ "r8" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 120.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of fees paid or payable to the entity's auditors for auditing services." } }, "en-us": { "role": { "label": "Auditor's remuneration for audit services", "terseLabel": "Audit and accounting" } } }, "localname": "AuditorsRemunerationForAuditServices", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r143" ], "calculation": { "http://predictmedix.com/role/AcquisitionsDetails": { "order": 0.0, "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for borrowings assumed in a business combination. [Refer: Borrowings; Business combinations [member]]" } }, "en-us": { "role": { "label": "Borrowings recognised as of acquisition date", "negatedLabel": "Loans payable", "terseLabel": "Loans payable" } } }, "localname": "BorrowingsRecognisedAsOfAcquisitionDate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/AcquisitionsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": { "auth_ref": [ "r48", "r52", "r76", "r79", "r83", "r84", "r85", "r86", "r87", "r145", "r159", "r160", "r184", "r186" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]" } } }, "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetails1", "http://predictmedix.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_CarryingAmountMember": { "auth_ref": [ "r52", "r79", "r83", "r85", "r86", "r145", "r159", "r160", "r184", "r185" ], "lang": { "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]" } }, "en-us": { "role": { "label": "Carrying amount [member]" } } }, "localname": "CarryingAmountMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetails1", "http://predictmedix.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_Cash": { "auth_ref": [ "r98" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]" } }, "en-us": { "role": { "label": "Cash", "periodEndLabel": "CASH, END OF PERIOD", "periodStartLabel": "CASH, BEGINNING OF PERIOD", "terseLabel": "Cash and cash equivalents", "totalLabel": "Total cash" } } }, "localname": "Cash", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashAndCashEquivalents": { "auth_ref": [ "r14", "r98", "r113" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 10.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } }, "en-us": { "role": { "label": "Cash and cash equivalents", "periodEndLabel": "CASH, END OF PERIOD", "periodStartLabel": "CASH, BEGINNING OF PERIOD", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalents", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/BasisOfPresentationAndGoingConcernDetails", "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition", "http://predictmedix.com/role/FinancialInstrumentsDetailTextuals" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r143" ], "calculation": { "http://predictmedix.com/role/AcquisitionsDetails": { "order": 30.0, "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Business combinations [member]]" } }, "en-us": { "role": { "label": "Cash and cash equivalents recognised as of acquisition date", "terseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsRecognisedAsOfAcquisitionDate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/AcquisitionsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "auth_ref": [ "r88", "r100" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity." } }, "en-us": { "role": { "label": "Cash flows from (used in) financing activities", "totalLabel": "CASH PROVIDED BY FINANCING ACTIVITIES" } } }, "localname": "CashFlowsFromUsedInFinancingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) financing activities [abstract]", "verboseLabel": "FINANCING ACTIVITIES" } } }, "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "auth_ref": [ "r88", "r100" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents." } }, "en-us": { "role": { "label": "Cash flows from (used in) investing activities", "totalLabel": "CASH USED IN INVESTING ACTIVITIES" } } }, "localname": "CashFlowsFromUsedInInvestingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) investing activities [abstract]", "verboseLabel": "INVESTING ACTIVITIES" } } }, "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "auth_ref": [ "r88", "r100" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 } }, "lang": { "en": { "role": { "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]" } }, "en-us": { "role": { "label": "Cash flows from (used in) operating activities", "totalLabel": "CASH USED IN OPERATING ACTIVITIES" } } }, "localname": "CashFlowsFromUsedInOperatingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) operating activities [abstract]", "verboseLabel": "OPERATING ACTIVITIES" } } }, "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "auth_ref": [ "r61" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Categories of related parties [axis]" } } }, "localname": "CategoriesOfRelatedPartiesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CommitmentsAndContingenciesDetailTextuals", "http://predictmedix.com/role/RelatedPartyTransactionsDetailTextuals", "http://predictmedix.com/role/RelatedPartyTransactionsDetails", "http://predictmedix.com/role/StockbasedCompensationDetailTextuals", "http://predictmedix.com/role/StockbasedCompensationDetails", "http://predictmedix.com/role/StockbasedCompensationTables" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfCashPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Classes of cash payments from operating activities [abstract]", "verboseLabel": "Changes in non-cash working capital:" } } }, "localname": "ClassesOfCashPaymentsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": { "auth_ref": [ "r80" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of intangible assets other than goodwill [axis]" } } }, "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/IntangibleAssetsDetailTextuals", "http://predictmedix.com/role/IntangibleAssetsDetails", "http://predictmedix.com/role/IntangibleAssetsDetails1", "http://predictmedix.com/role/PrepaidExpensesDetailTextuals" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": { "auth_ref": [ "r53" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of property, plant and equipment [axis]" } } }, "localname": "ClassesOfPropertyPlantAndEquipmentAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/PropertyAndEquipmentDetails", "http://predictmedix.com/role/SignificantAccountingPoliciesDetailTextuals" ], "xbrltype": "stringItemType" }, "ifrs-full_ComponentsOfEquityAxis": { "auth_ref": [ "r6" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Components of equity [axis]" } } }, "localname": "ComponentsOfEquityAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "ifrs-full_CostOfSales": { "auth_ref": [ "r2", "r36" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 10.0, "parentTag": "ifrs-full_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories." } }, "en-us": { "role": { "label": "Cost of sales", "terseLabel": "Cost of revenue" } } }, "localname": "CostOfSales", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CreditRiskMember": { "auth_ref": [ "r156", "r179", "r180", "r181" ], "lang": { "en": { "role": { "documentation": "This member stands for the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an obligation. [Refer: Financial instruments, class [member]]" } }, "en-us": { "role": { "label": "Credit risk [member]", "terseLabel": "Credit risk [Member]" } } }, "localname": "CreditRiskMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/BusinessSegmentAndConcentrationDetailTextuals", "http://predictmedix.com/role/FinancialInstrumentsDetailTextuals" ], "xbrltype": "domainItemType" }, "ifrs-full_CurrentAssets": { "auth_ref": [ "r19", "r108", "r109" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 0.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } }, "en-us": { "role": { "label": "Current assets", "totalLabel": "Total current assets" } } }, "localname": "CurrentAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets [abstract]", "verboseLabel": "CURRENT" } } }, "localname": "CurrentAssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r143" ], "calculation": { "http://predictmedix.com/role/AcquisitionsDetails": { "order": 20.0, "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Expiry date 2022-01-01: The amount recognised as of the acquisition date for current assets acquired in a business combination. [Refer: Business combinations [member]]\nEffective 2022-01-01: The amount recognised as of the acquisition date for current assets acquired in a business combination. [Refer: Current assets; Business combinations [member]]" } }, "en-us": { "role": { "label": "Current assets recognised as of acquisition date", "terseLabel": "Prepaid expenses" } } }, "localname": "CurrentAssetsRecognisedAsOfAcquisitionDate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/AcquisitionsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities": { "auth_ref": [ "r17", "r24" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 0.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current deferred income other than current contract liabilities. [Refer: Deferred income other than contract liabilities]" } }, "en-us": { "role": { "label": "Current deferred income other than current contract liabilities", "terseLabel": "Deferred revenue" } } }, "localname": "CurrentDeferredIncomeOtherThanCurrentContractLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLeaseLiabilities": { "auth_ref": [ "r120" ], "calculation": { "http://predictmedix.com/role/LeasesDetails2": { "order": 0.0, "parentTag": "ifrs-full_LeaseLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Current lease liabilities", "terseLabel": "Lease liability - current" } } }, "localname": "CurrentLeaseLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/LeasesDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLiabilities": { "auth_ref": [ "r21", "r108", "r110" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.\nEffective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } }, "en-us": { "role": { "label": "Current liabilities" } } }, "localname": "CurrentLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/FinancialInstrumentsDetailTextuals" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities [abstract]", "terseLabel": "CURRENT" } } }, "localname": "CurrentLiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentPrepaidExpenses": { "auth_ref": [ "r8" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 0.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised." } }, "en-us": { "role": { "label": "Current prepaid expenses", "terseLabel": "Prepaid expenses" } } }, "localname": "CurrentPrepaidExpenses", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition", "http://predictmedix.com/role/PrepaidExpensesDetailTextuals" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentTradeReceivables": { "auth_ref": [ "r20", "r22" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 20.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current trade receivables. [Refer: Trade receivables]" } }, "en-us": { "role": { "label": "Current trade receivables", "terseLabel": "Accounts receivable" } } }, "localname": "CurrentTradeReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentValueAddedTaxReceivables": { "auth_ref": [ "r22" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 30.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current value added tax receivables. [Refer: Value added tax receivables]" } }, "en-us": { "role": { "label": "Current value added tax receivables", "terseLabel": "Sales tax receivable" } } }, "localname": "CurrentValueAddedTaxReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment": { "auth_ref": [ "r50" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The decrease in property, plant and equipment through classification as held for sale or inclusion in a disposal group classified as held for sale. [Refer: Disposal groups classified as held for sale [member]; Property, plant and equipment; Disposal groups classified as held for sale [member]]" } }, "en-us": { "role": { "label": "Decrease through classified as held for sale, property, plant and equipment", "negatedLabel": "Decrease through classified as held for sale, property, plant and equipment", "terseLabel": "Discontinuance of business" } } }, "localname": "DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised": { "auth_ref": [ "r41" ], "lang": { "en": { "role": { "documentation": "The amount of deductible temporary differences for which no deferred tax asset is recognised in the statement of financial position. [Refer: Temporary differences [member]]" } }, "en-us": { "role": { "label": "Deductible temporary differences for which no deferred tax asset is recognised", "verboseLabel": "Temporary differences" } } }, "localname": "DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DeferredTaxAssets": { "auth_ref": [ "r16", "r18", "r42" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]" } }, "en-us": { "role": { "label": "Deferred tax assets", "verboseLabel": "Total deferred tax assets" } } }, "localname": "DeferredTaxAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DepreciationPropertyPlantAndEquipment": { "auth_ref": [ "r51", "r54" ], "lang": { "en": { "role": { "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]" } }, "en-us": { "role": { "label": "Depreciation, property, plant and equipment", "negatedLabel": "Amortization", "terseLabel": "Amortization" } } }, "localname": "DepreciationPropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DepreciationRatePropertyPlantAndEquipment": { "auth_ref": [ "r47" ], "lang": { "en": { "role": { "documentation": "The depreciation rate used for property, plant and equipment. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Depreciation rate, property, plant and equipment", "verboseLabel": "Property and equipment amortization rate" } } }, "localname": "DepreciationRatePropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/SignificantAccountingPoliciesDetailTextuals" ], "xbrltype": "percentItemType" }, "ifrs-full_DepreciationRightofuseAssets": { "auth_ref": [ "r121" ], "lang": { "en": { "role": { "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]" } }, "en-us": { "role": { "label": "Depreciation, right-of-use assets", "negatedTerseLabel": "Amortization", "terseLabel": "Amortization" } } }, "localname": "DepreciationRightofuseAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": { "auth_ref": [ "r9" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for earnings per share." } }, "en-us": { "role": { "label": "Description of accounting policy for earnings per share [text block]", "verboseLabel": "Loss per share [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory": { "auth_ref": [ "r9" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for financial instruments. [Refer: Financial instruments, class [member]]" } }, "en-us": { "role": { "label": "Description of accounting policy for financial instruments [text block]", "terseLabel": "Financial Instruments [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": { "auth_ref": [ "r9" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for foreign currency translation." } }, "en-us": { "role": { "label": "Description of accounting policy for foreign currency translation [text block]", "terseLabel": "Foreign currency translation [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory": { "auth_ref": [ "r9" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for the impairment of assets." } }, "en-us": { "role": { "label": "Description of accounting policy for impairment of assets [text block]", "terseLabel": "Impairment [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": { "auth_ref": [ "r9" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for income tax." } }, "en-us": { "role": { "label": "Description of accounting policy for income tax [text block]", "terseLabel": "Income taxes [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory": { "auth_ref": [ "r9" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Description of accounting policy for intangible assets other than goodwill [text block]", "terseLabel": "Intangible assets [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory": { "auth_ref": [ "r9" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for issued capital. [Refer: Issued capital]" } }, "en-us": { "role": { "label": "Description of accounting policy for issued capital [text block]", "terseLabel": "Share Capital [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForIssuedCapitalExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": { "auth_ref": [ "r9" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Description of accounting policy for property, plant and equipment [text block]", "terseLabel": "Property and equipment: [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": { "auth_ref": [ "r9" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]" } }, "en-us": { "role": { "label": "Description of accounting policy for share-based payment transactions [text block]", "terseLabel": "Share-based payments [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": { "auth_ref": [ "r99" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]" } }, "en-us": { "role": { "label": "Description of accounting policy for determining components of cash and cash equivalents [text block]", "terseLabel": "Cash [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": { "auth_ref": [ "r139" ], "lang": { "en": { "role": { "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time." } }, "en-us": { "role": { "label": "Expected volatility, share options granted", "verboseLabel": "Expected volatility" } } }, "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement": { "auth_ref": [ "r129" ], "lang": { "en": { "role": { "documentation": "The description of the maximum term of options granted for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]]" } }, "en-us": { "role": { "label": "Description of maximum term of options granted for share-based payment arrangement", "verboseLabel": "Maximum term of options granted for share-based payment arrangement" } } }, "localname": "DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals" ], "xbrltype": "stringItemType" }, "ifrs-full_DescriptionOfOptionLifeShareOptionsGranted": { "auth_ref": [ "r139" ], "lang": { "en": { "role": { "documentation": "The option life of share options granted." } }, "en-us": { "role": { "label": "Option life, share options granted", "verboseLabel": "Expected life" } } }, "localname": "DescriptionOfOptionLifeShareOptionsGranted", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": { "auth_ref": [ "r139" ], "lang": { "en": { "role": { "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]" } }, "en-us": { "role": { "label": "Risk free interest rate, share options granted", "verboseLabel": "Risk free rate" } } }, "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_DilutedEarningsLossPerShare": { "auth_ref": [ "r70", "r71" ], "lang": { "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } }, "en-us": { "role": { "label": "Diluted earnings (loss) per share", "terseLabel": "Loss per share-Basic and Diluted" } } }, "localname": "DilutedEarningsLossPerShare", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory": { "auth_ref": [ "r125" ], "lang": { "en": { "role": { "documentation": "The disclosure of additional information about leasing activities of a lessee." } }, "en-us": { "role": { "label": "Disclosure of additional information about leasing activities for lessee [text block]", "terseLabel": "Disclosure of lease liability interest expense recognized [Table Text Block]" } } }, "localname": "DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of analysis of single amount of discontinued operations [line items]" } } }, "localname": "DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedDetailTextuals" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable": { "auth_ref": [ "r152" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the analysis of the single amount of discontinued operations." } }, "en-us": { "role": { "label": "Disclosure of analysis of single amount of discontinued operations [table]" } } }, "localname": "DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedDetailTextuals" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfBusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about business combination [abstract]" } } }, "localname": "DisclosureOfBusinessCombinationsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/AcquisitionsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfBusinessCombinationsExplanatory": { "auth_ref": [ "r147" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for business combinations." } }, "en-us": { "role": { "label": "Disclosure of business combinations [text block]", "terseLabel": "Acquisitions [Text Block]" } } }, "localname": "DisclosureOfBusinessCombinationsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/Acquisitions" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfBusinessCombinationsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of detailed information about business combination [line items]" } } }, "localname": "DisclosureOfBusinessCombinationsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/AcquisitionsDetailTextuals", "http://predictmedix.com/role/AcquisitionsDetails", "http://predictmedix.com/role/OrganizationAndNatureOfOperationsDetailTextuals" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfBusinessCombinationsTable": { "auth_ref": [ "r144" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of business combinations." } }, "en-us": { "role": { "label": "Disclosure of detailed information about business combination [table]" } } }, "localname": "DisclosureOfBusinessCombinationsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/AcquisitionsDetailTextuals", "http://predictmedix.com/role/OrganizationAndNatureOfOperationsDetailTextuals" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfClassesOfShareCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of classes of share capital [abstract]" } } }, "localname": "DisclosureOfClassesOfShareCapitalAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": { "auth_ref": [ "r27" ], "lang": { "en": { "role": { "documentation": "The disclosure of classes of share capital. [Refer: Share capital [member]]" } }, "en-us": { "role": { "label": "Disclosure of classes of share capital [text block]", "terseLabel": "Capital Stock [Text Block]" } } }, "localname": "DisclosureOfClassesOfShareCapitalExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStock" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of classes of share capital [line items]" } } }, "localname": "DisclosureOfClassesOfShareCapitalLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfClassesOfShareCapitalTable": { "auth_ref": [ "r27" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to classes of share capital." } }, "en-us": { "role": { "label": "Disclosure of classes of share capital [table]" } } }, "localname": "DisclosureOfClassesOfShareCapitalTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of commitments and contingent liabilities. [Refer: Contingent liabilities [member]]" } }, "en-us": { "role": { "label": "Disclosure of commitments and contingent liabilities [text block]", "terseLabel": "Commitments and Contingencies [Text Block]" } } }, "localname": "DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDeferredTaxesExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]" } }, "en-us": { "role": { "label": "Disclosure of deferred taxes [text block]", "verboseLabel": "Disclosure of deferred taxes [Table Text Block]" } } }, "localname": "DisclosureOfDeferredTaxesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory": { "auth_ref": [ "r148" ], "lang": { "en": { "role": { "documentation": "The disclosure of detailed information about business combinations. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Disclosure of detailed information about business combination [text block]", "terseLabel": "Disclosure of fair value of the acquired assets and liabilities assumed [Table Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": { "auth_ref": [ "r80" ], "lang": { "en": { "role": { "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [text block]", "verboseLabel": "Disclosure of detailed information about intangible assets [Table Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": { "auth_ref": [ "r53" ], "lang": { "en": { "role": { "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [text block]", "terseLabel": "Disclosure of property and equipment [Table Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/PropertyAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of discontinued operations. [Refer: Discontinued operations [member]]" } }, "en-us": { "role": { "label": "Disclosure of discontinued operations [text block]", "terseLabel": "Disclosure of Income (loss) from discontinued operations [Table Text Block]" } } }, "localname": "DisclosureOfDiscontinuedOperationsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFinancialInstrumentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about financial instruments [abstract]" } } }, "localname": "DisclosureOfFinancialInstrumentsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": { "auth_ref": [ "r165" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for financial instruments." } }, "en-us": { "role": { "label": "Disclosure of financial instruments [text block]", "terseLabel": "Financial Instruments [Text Block]" } } }, "localname": "DisclosureOfFinancialInstrumentsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/FinancialInstruments" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFinancialInstrumentsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of detailed information about financial instruments [line items]" } } }, "localname": "DisclosureOfFinancialInstrumentsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/FinancialInstrumentsDetailTextuals" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfFinancialInstrumentsTable": { "auth_ref": [ "r155", "r161", "r164" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of financial instruments." } }, "en-us": { "role": { "label": "Disclosure of detailed information about financial instruments [table]" } } }, "localname": "DisclosureOfFinancialInstrumentsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/FinancialInstrumentsDetailTextuals" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfIncomeTaxExplanatory": { "auth_ref": [ "r44" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for income taxes." } }, "en-us": { "role": { "label": "Disclosure of income tax [text block]", "verboseLabel": "Income Taxes [Text Block]" } } }, "localname": "DisclosureOfIncomeTaxExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Disclosure of information about key management personnel [text block]", "terseLabel": "Disclosure of transactions with key management personnel [Table Text Block]" } } }, "localname": "DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/RelatedPartyTransactionsTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfIntangibleAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [abstract]" } } }, "localname": "DisclosureOfIntangibleAssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": { "auth_ref": [ "r82" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for intangible assets." } }, "en-us": { "role": { "label": "Disclosure of intangible assets [text block]", "verboseLabel": "Intangible Assets [Text Block]" } } }, "localname": "DisclosureOfIntangibleAssetsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [line items]" } } }, "localname": "DisclosureOfIntangibleAssetsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetailTextuals", "http://predictmedix.com/role/IntangibleAssetsDetails", "http://predictmedix.com/role/IntangibleAssetsDetails1", "http://predictmedix.com/role/PrepaidExpensesDetailTextuals" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfIntangibleAssetsTable": { "auth_ref": [ "r80" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of intangible assets." } }, "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [table]" } } }, "localname": "DisclosureOfIntangibleAssetsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetailTextuals", "http://predictmedix.com/role/IntangibleAssetsDetails1", "http://predictmedix.com/role/PrepaidExpensesDetailTextuals" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfLeasesExplanatory": { "auth_ref": [ "r126", "r127" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for leases." } }, "en-us": { "role": { "label": "Disclosure of leases [text block]", "terseLabel": "Leases [Text Block]" } } }, "localname": "DisclosureOfLeasesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory": { "auth_ref": [ "r153" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for non-current assets held for sale and discontinued operations." } }, "en-us": { "role": { "label": "Disclosure of non-current assets held for sale and discontinued operations [text block]", "terseLabel": "Sale of interest in Cultivar JA Limited [Text Block]" } } }, "localname": "DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/SaleOfInterestInCultivarJALimited" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory": { "auth_ref": [ "r138" ], "lang": { "en": { "role": { "documentation": "The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options)." } }, "en-us": { "role": { "label": "Disclosure of number and weighted average exercise prices of other equity instruments [text block]", "terseLabel": "Disclosure of continuity of warrants [Table Text Block]" } } }, "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": { "auth_ref": [ "r136" ], "lang": { "en": { "role": { "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Disclosure of number and weighted average exercise prices of share options [text block]", "verboseLabel": "Disclosure of number and weighted average exercise prices of share options [Table Text Block]" } } }, "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory": { "auth_ref": [ "r137" ], "lang": { "en": { "role": { "documentation": "The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [text block]", "verboseLabel": "Disclosure of number and weighted average remaining contractual life of outstanding share options [Table Text Block]" } } }, "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory": { "auth_ref": [ "r11" ], "lang": { "en": { "role": { "documentation": "The disclosure of information that enables users of financial statements to evaluate the entity's objectives, policies and processes for managing capital." } }, "en-us": { "role": { "label": "Disclosure of objectives, policies and processes for managing capital [text block]", "terseLabel": "Capital Management [Text Block]" } } }, "localname": "DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalManagement" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfOperatingSegmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of operating segments [abstract]" } } }, "localname": "DisclosureOfOperatingSegmentsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": { "auth_ref": [ "r169" ], "lang": { "en": { "role": { "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]" } }, "en-us": { "role": { "label": "Disclosure of operating segments [text block]", "verboseLabel": "Business Segment and Concentration [Text Block]" } } }, "localname": "DisclosureOfOperatingSegmentsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/BusinessSegmentAndConcentration" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfOperatingSegmentsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of operating segments [line items]" } } }, "localname": "DisclosureOfOperatingSegmentsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/BusinessSegmentAndConcentrationDetailTextuals" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfOperatingSegmentsTable": { "auth_ref": [ "r169" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to operating segments." } }, "en-us": { "role": { "label": "Disclosure of operating segments [table]" } } }, "localname": "DisclosureOfOperatingSegmentsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/BusinessSegmentAndConcentrationDetailTextuals" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": { "auth_ref": [ "r56" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for property, plant and equipment." } }, "en-us": { "role": { "label": "Disclosure of property, plant and equipment [text block]", "terseLabel": "Property and Equipment [Text Block]" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/PropertyAndEquipment" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [line items]" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/PropertyAndEquipmentDetails", "http://predictmedix.com/role/SignificantAccountingPoliciesDetailTextuals" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r53" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of property, plant and equipment." } }, "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [table]" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/PropertyAndEquipmentDetails", "http://predictmedix.com/role/SignificantAccountingPoliciesDetailTextuals" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": { "auth_ref": [ "r124" ], "lang": { "en": { "role": { "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]" } }, "en-us": { "role": { "label": "Disclosure of quantitative information about right-of-use assets [text block]", "terseLabel": "Disclosure of right of use assets [Table Text Block]" } } }, "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfRelatedPartyExplanatory": { "auth_ref": [ "r63" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for related parties." } }, "en-us": { "role": { "label": "Disclosure of related party [text block]", "verboseLabel": "Related Party Transactions [Text Block]" } } }, "localname": "DisclosureOfRelatedPartyExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": { "auth_ref": [ "r128" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for share-based payment arrangements." } }, "en-us": { "role": { "label": "Disclosure of share-based payment arrangements [text block]", "verboseLabel": "Stock-based compensation [Text Block]" } } }, "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/StockbasedCompensation" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for significant accounting policies applied by the entity." } }, "en-us": { "role": { "label": "Disclosure of significant accounting policies [text block]", "terseLabel": "Significant Accounting Policies [Text Block]" } } }, "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/SignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [line items]" } } }, "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable": { "auth_ref": [ "r43" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to temporary differences, unused tax losses and unused tax credits." } }, "en-us": { "role": { "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]" } } }, "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of terms and conditions of share-based payment arrangement [line items]" } } }, "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals", "http://predictmedix.com/role/StockbasedCompensationDetails", "http://predictmedix.com/role/StockbasedCompensationDetails2", "http://predictmedix.com/role/StockbasedCompensationTables" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": { "auth_ref": [ "r138" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements." } }, "en-us": { "role": { "label": "Disclosure of terms and conditions of share-based payment arrangement [table]" } } }, "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals", "http://predictmedix.com/role/StockbasedCompensationDetails", "http://predictmedix.com/role/StockbasedCompensationDetails2", "http://predictmedix.com/role/StockbasedCompensationTables" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of transactions between related parties [abstract]" } } }, "localname": "DisclosureOfTransactionsBetweenRelatedPartiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of transactions between related parties [line items]" } } }, "localname": "DisclosureOfTransactionsBetweenRelatedPartiesLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CommitmentsAndContingenciesDetailTextuals", "http://predictmedix.com/role/RelatedPartyTransactionsDetailTextuals", "http://predictmedix.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": { "auth_ref": [ "r61" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to transactions between related parties." } }, "en-us": { "role": { "label": "Disclosure of transactions between related parties [table]" } } }, "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CommitmentsAndContingenciesDetailTextuals", "http://predictmedix.com/role/RelatedPartyTransactionsDetailTextuals", "http://predictmedix.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_EntitysTotalForRelatedPartiesMember": { "auth_ref": [ "r61" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } }, "en-us": { "role": { "label": "Entity's total for related parties [member]" } } }, "localname": "EntitysTotalForRelatedPartiesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CommitmentsAndContingenciesDetailTextuals", "http://predictmedix.com/role/RelatedPartyTransactionsDetailTextuals", "http://predictmedix.com/role/RelatedPartyTransactionsDetails", "http://predictmedix.com/role/StockbasedCompensationDetailTextuals", "http://predictmedix.com/role/StockbasedCompensationDetails", "http://predictmedix.com/role/StockbasedCompensationTables" ], "xbrltype": "domainItemType" }, "ifrs-full_EntitysTotalForSubsidiariesMember": { "auth_ref": [ "r67", "r69", "r116" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used." } }, "en-us": { "role": { "label": "Entity's total for subsidiaries [member]" } } }, "localname": "EntitysTotalForSubsidiariesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/AcquisitionsDetailTextuals", "http://predictmedix.com/role/AcquisitionsDetails", "http://predictmedix.com/role/BasisOfPresentationAndGoingConcernDetails", "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/OrganizationAndNatureOfOperationsDetailTextuals", "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedDetailTextuals", "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_Equity": { "auth_ref": [ "r17", "r23", "r101", "r103", "r117", "r118", "r119" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 10.0, "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } }, "en-us": { "role": { "label": "Equity", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "positiveLabel": "Ending balance", "terseLabel": "Beginning balance", "totalLabel": "TOTAL SHAREHOLDERS' EQUITY", "verboseLabel": "Shareholders' equity" } } }, "localname": "Equity", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalManagementDetailTextuals", "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity", "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [abstract]", "verboseLabel": "SHAREHOLDERS' EQUITY" } } }, "localname": "EquityAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_EquityAndLiabilities": { "auth_ref": [ "r17" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } }, "en-us": { "role": { "label": "Equity and liabilities", "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY" } } }, "localname": "EquityAndLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity and liabilities [abstract]", "verboseLabel": "LIABILITIES AND SHAREHOLDERS' EQUITY" } } }, "localname": "EquityAndLiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_EquityInterestsOfAcquirer": { "auth_ref": [ "r141" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Equity interests of acquirer", "terseLabel": "Consideration value as of acquisition date" } } }, "localname": "EquityInterestsOfAcquirer", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/AcquisitionsDetailTextuals" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityMember": { "auth_ref": [ "r6" ], "lang": { "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } }, "en-us": { "role": { "label": "Equity [member]" } } }, "localname": "EquityMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_ExercisePriceOfOutstandingShareOptions2019": { "auth_ref": [ "r137" ], "lang": { "en": { "role": { "documentation": "The exercise price of outstanding share options." } }, "en-us": { "role": { "label": "Exercise price of outstanding share options", "verboseLabel": "Exercise Price" } } }, "localname": "ExercisePriceOfOutstandingShareOptions2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetails2" ], "xbrltype": "perShareItemType" }, "ifrs-full_ExercisePriceShareOptionsGranted2019": { "auth_ref": [ "r139" ], "lang": { "en": { "role": { "documentation": "The exercise price of share options granted." } }, "en-us": { "role": { "label": "Exercise price, share options granted", "verboseLabel": "Exercise price, share options granted" } } }, "localname": "ExercisePriceShareOptionsGranted2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals" ], "xbrltype": "perShareItemType" }, "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": { "auth_ref": [ "r139" ], "lang": { "en": { "role": { "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted." } }, "en-us": { "role": { "label": "Expected dividend as percentage, share options granted", "verboseLabel": "Expected dividends" } } }, "localname": "ExpectedDividendAsPercentageShareOptionsGranted", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_ExpenseByNatureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expenses by nature [abstract]", "verboseLabel": "Expenses" } } }, "localname": "ExpenseByNatureAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": { "auth_ref": [ "r8" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 110.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]" } }, "en-us": { "role": { "label": "Expense from share-based payment transactions with employees", "terseLabel": "Share based compensation", "verboseLabel": "Vested stock-based compensation expense" } } }, "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://predictmedix.com/role/StockbasedCompensationDetailTextuals" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation": { "auth_ref": [ "r151" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The gain (loss) recognised on the measurement to fair value less costs to sell or on the disposal of the assets or disposal group(s) constituting the discontinued operation. [Refer: Discontinued operations [member]]" } }, "en-us": { "role": { "label": "Gain (loss) recognised on measurement to fair value less costs to sell or on disposal of assets or disposal groups constituting discontinued operation", "terseLabel": "Gain on divestiture" } } }, "localname": "GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GeneralAndAdministrativeExpense": { "auth_ref": [ "r8" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 30.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense relating to general and administrative activities of the entity." } }, "en-us": { "role": { "label": "General and administrative expense", "terseLabel": "Administration and general" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GrossCarryingAmountMember": { "auth_ref": [ "r48", "r76", "r84", "r87", "r145", "r160", "r162", "r163", "r184", "r186" ], "lang": { "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]" } }, "en-us": { "role": { "label": "Gross carrying amount [member]", "terseLabel": "Cost [Member]", "verboseLabel": "Cost [Member]" } } }, "localname": "GrossCarryingAmountMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetails1", "http://predictmedix.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_GrossProfit": { "auth_ref": [ "r2" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 10.0, "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]" } }, "en-us": { "role": { "label": "Gross profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed": { "auth_ref": [ "r143", "r146" ], "calculation": { "http://predictmedix.com/role/AcquisitionsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Identifiable assets acquired (liabilities assumed)", "negatedTotalLabel": "Net liabilities assumed", "totalLabel": "Net liabilities assumed" } } }, "localname": "IdentifiableAssetsAcquiredLiabilitiesAssumed", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/AcquisitionsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Profit or loss [abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "auth_ref": [ "r32", "r38", "r39", "r40", "r65", "r115", "r168" ], "calculation": { "http://predictmedix.com/role/IncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]" } }, "en-us": { "role": { "label": "Tax expense (income)", "totalLabel": "Total income tax recovery" } } }, "localname": "IncomeTaxExpenseContinuingOperations", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncomeTaxesPaidRefund": { "auth_ref": [ "r97" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash flows from income taxes paid or refunded." } }, "en-us": { "role": { "label": "Income taxes paid (refund)", "terseLabel": "Cash paid for interest and income taxes" } } }, "localname": "IncomeTaxesPaidRefund", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": { "auth_ref": [ "r98" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } }, "en-us": { "role": { "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes", "totalLabel": "NET CHANGE IN CASH DURING THE PERIOD" } } }, "localname": "IncreaseDecreaseInCashAndCashEquivalents", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary": { "auth_ref": [ "r5" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the disposal of subsidiaries. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Increase (decrease) through disposal of subsidiary, equity", "negatedLabel": "Sale of Cultivar Jamaica", "terseLabel": "Sale of Cultivar Jamaica" } } }, "localname": "IncreaseDecreaseThroughDisposalOfSubsidiary", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity", "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedDetailTextuals" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughExerciseOfOptions": { "auth_ref": [ "r5" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the exercise of options." } }, "en-us": { "role": { "label": "Increase (decrease) through exercise of options, equity", "terseLabel": "Exercise of options" } } }, "localname": "IncreaseDecreaseThroughExerciseOfOptions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity": { "auth_ref": [ "r5" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the exercise of warrants." } }, "en-us": { "role": { "label": "Increase (decrease) through exercise of warrants, equity", "terseLabel": "Exercise of warrants" } } }, "localname": "IncreaseDecreaseThroughExerciseOfWarrantsEquity", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "auth_ref": [ "r4" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } }, "en-us": { "role": { "label": "Increase (decrease) through share-based payment transactions, equity", "terseLabel": "Share-based compensation" } } }, "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r13", "r79" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 10.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]" } }, "en-us": { "role": { "label": "Intangible assets other than goodwill", "periodEndLabel": "Intangible assets other than goodwill at end of period", "periodStartLabel": "Intangible assets other than goodwill at beginning of period", "terseLabel": "Intangible assets", "totalLabel": "Total intangible assets other than goodwill" } } }, "localname": "IntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition", "http://predictmedix.com/role/IntangibleAssetsDetails", "http://predictmedix.com/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": { "auth_ref": [ "r73", "r80", "r124" ], "lang": { "en": { "role": { "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Intangible assets other than goodwill [member]" } } }, "localname": "IntangibleAssetsOtherThanGoodwillMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/IntangibleAssetsDetailTextuals", "http://predictmedix.com/role/IntangibleAssetsDetails", "http://predictmedix.com/role/IntangibleAssetsDetails1", "http://predictmedix.com/role/PrepaidExpensesDetailTextuals" ], "xbrltype": "domainItemType" }, "ifrs-full_InterestExpense": { "auth_ref": [ "r114", "r167", "r174" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense arising from interest." } }, "en-us": { "role": { "label": "Interest expense", "verboseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InterestExpenseOnLeaseLiabilities": { "auth_ref": [ "r122" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Interest expense on lease liabilities", "terseLabel": "Interest expense" } } }, "localname": "InterestExpenseOnLeaseLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/LeasesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IssuedCapital": { "auth_ref": [ "r23" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 0.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The nominal value of capital issued." } }, "en-us": { "role": { "label": "Issued capital", "terseLabel": "Share Capital" } } }, "localname": "IssuedCapital", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IssuedCapitalMember": { "auth_ref": [ "r6" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing issued capital." } }, "en-us": { "role": { "label": "Issued capital [member]", "verboseLabel": "Share capital [Member]" } } }, "localname": "IssuedCapitalMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_KeyManagementPersonnelCompensation": { "auth_ref": [ "r58" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Key management personnel compensation", "terseLabel": "Monthly compensation" } } }, "localname": "KeyManagementPersonnelCompensation", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LeaseLiabilities": { "auth_ref": [ "r120" ], "calculation": { "http://predictmedix.com/role/LeasesDetails2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration." } }, "en-us": { "role": { "label": "Lease liabilities", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "terseLabel": "Total lease liability", "totalLabel": "Total lease liability" } } }, "localname": "LeaseLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/LeasesDetailTextuals", "http://predictmedix.com/role/LeasesDetails1", "http://predictmedix.com/role/LeasesDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LeaseLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease liabilities [abstract]" } } }, "localname": "LeaseLiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_LeaseholdImprovementsMember": { "auth_ref": [ "r46" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement." } }, "en-us": { "role": { "label": "Leasehold improvements [member]", "terseLabel": "Leasehold Improvement [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_Liabilities": { "auth_ref": [ "r17", "r117", "r118", "r119", "r169", "r173" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 0.0, "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } }, "en-us": { "role": { "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [abstract]", "verboseLabel": "LIABILITIES" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_LiquidityRiskMember": { "auth_ref": [ "r156", "r179", "r180", "r181" ], "lang": { "en": { "role": { "documentation": "This member stands for the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities that are settled by delivering cash or another financial asset. [Refer: Financial assets; Financial liabilities]" } }, "en-us": { "role": { "label": "Liquidity risk [member]", "terseLabel": "Liquidity risk [Member]" } } }, "localname": "LiquidityRiskMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/FinancialInstrumentsDetailTextuals" ], "xbrltype": "domainItemType" }, "ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Major components of tax expense (income) [abstract]" } } }, "localname": "MajorComponentsOfTaxExpenseIncomeAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_MajorCustomersMember": { "auth_ref": [ "r177" ], "lang": { "en": { "role": { "documentation": "This member stands for customers. It also represents the standard value for the 'Major customers' axis if no other member is used." } }, "en-us": { "role": { "label": "Customers [member]" } } }, "localname": "MajorCustomersMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/BusinessSegmentAndConcentrationDetailTextuals", "http://predictmedix.com/role/FinancialInstrumentsDetailTextuals" ], "xbrltype": "domainItemType" }, "ifrs-full_NetDeferredTaxAssets": { "auth_ref": [ "r42" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]" } }, "en-us": { "role": { "label": "Net deferred tax assets", "verboseLabel": "Net deferred tax assets" } } }, "localname": "NetDeferredTaxAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncontrollingInterestsMember": { "auth_ref": [ "r6" ], "lang": { "en": { "role": { "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent." } }, "en-us": { "role": { "label": "Non-controlling interests [member]", "verboseLabel": "Non-controlling interests [Member]" } } }, "localname": "NoncontrollingInterestsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_NoncurrentLeaseLiabilities": { "auth_ref": [ "r120" ], "calculation": { "http://predictmedix.com/role/LeasesDetails2": { "order": 10.0, "parentTag": "ifrs-full_LeaseLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Non-current lease liabilities", "terseLabel": "Lease liability - non- current" } } }, "localname": "NoncurrentLeaseLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/LeasesDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable": { "auth_ref": [ "r141" ], "lang": { "en": { "role": { "documentation": "The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration in a business combination." } }, "en-us": { "role": { "label": "Number of instruments or interests issued or issuable", "verboseLabel": "Number of shares issued under consideration" } } }, "localname": "NumberOfInstrumentsOrInterestsIssuedOrIssuable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/AcquisitionsDetailTextuals" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": { "auth_ref": [ "r138", "r140" ], "lang": { "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of other equity instruments granted in share-based payment arrangement", "terseLabel": "Number of warrants issued" } } }, "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement": { "auth_ref": [ "r138" ], "lang": { "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of other equity instruments exercised or vested in share-based payment arrangement", "negatedLabel": "Number of warrants exercised", "terseLabel": "Number of warrants exercised", "verboseLabel": "Number of share options vested in share-based payment arrangement" } } }, "localname": "NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/CapitalStockDetails", "http://predictmedix.com/role/StockbasedCompensationDetailTextuals" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement": { "auth_ref": [ "r138" ], "lang": { "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) expired in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of other equity instruments expired in share-based payment arrangement", "negatedLabel": "Number of warrants expired" } } }, "localname": "NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement": { "auth_ref": [ "r138" ], "lang": { "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of other equity instruments outstanding in share-based payment arrangement", "periodEndLabel": "Number of warrants outstanding at end of period", "periodStartLabel": "Number of warrants outstanding at beginning of period", "terseLabel": "Warrants Outstanding" } } }, "localname": "NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetails", "http://predictmedix.com/role/CapitalStockDetails1" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfOutstandingShareOptions": { "auth_ref": [ "r130", "r134", "r137" ], "lang": { "en": { "role": { "documentation": "The number of share options outstanding in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options outstanding in share-based payment arrangement", "periodEndLabel": "Number of options outstanding, end of period", "periodStartLabel": "Number of options outstanding, beginning of period", "verboseLabel": "Outstanding" } } }, "localname": "NumberOfOutstandingShareOptions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetails1", "http://predictmedix.com/role/StockbasedCompensationDetails2" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement": { "auth_ref": [ "r135" ], "lang": { "en": { "role": { "documentation": "The number of share options exercisable in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options exercisable in share-based payment arrangement", "verboseLabel": "Exercisable" } } }, "localname": "NumberOfShareOptionsExercisableInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetails2" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": { "auth_ref": [ "r132" ], "lang": { "en": { "role": { "documentation": "The number of share options exercised in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options exercised in share-based payment arrangement", "negatedLabel": "Number of options, exercised", "terseLabel": "Number of share options exercised", "verboseLabel": "Number of share options exercised in share-based payment arrangement" } } }, "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/StockbasedCompensationDetails1" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement": { "auth_ref": [ "r133" ], "lang": { "en": { "role": { "documentation": "The number of share options expired in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options expired in share-based payment arrangement", "negatedLabel": "Number of options, expired", "verboseLabel": "Number of share options expired in share-based payment arrangement" } } }, "localname": "NumberOfShareOptionsExpiredInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetails1" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": { "auth_ref": [ "r131" ], "lang": { "en": { "role": { "documentation": "The number of share options granted in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options granted in share-based payment arrangement", "terseLabel": "Number of options, granted", "verboseLabel": "Number of share options granted in share-based payment arrangement" } } }, "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals", "http://predictmedix.com/role/StockbasedCompensationDetails1" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfSharesIssued": { "auth_ref": [ "r5" ], "lang": { "en": { "role": { "documentation": "The number of shares issued by the entity." } }, "en-us": { "role": { "label": "Number of shares issued", "verboseLabel": "Number of shares issue" } } }, "localname": "NumberOfSharesIssued", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "sharesItemType" }, "ifrs-full_NumberOfSharesOutstanding": { "auth_ref": [ "r25" ], "lang": { "en": { "role": { "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]" } }, "en-us": { "role": { "label": "Number of shares outstanding", "periodEndLabel": "Ending balance (Shares)", "periodStartLabel": "Beginning balance (Shares)", "terseLabel": "Beginning balance (shares)" } } }, "localname": "NumberOfSharesOutstanding", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "ifrs-full_OfficeEquipmentMember": { "auth_ref": [ "r45" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing equipment used to support office functions, not specifically used in the production process. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Office equipment [member]", "terseLabel": "Equipment [Member]" } } }, "localname": "OfficeEquipmentMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_OperatingExpense": { "auth_ref": [ "r34" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 20.0, "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of all operating expenses." } }, "en-us": { "role": { "label": "Operating expense", "negatedTotalLabel": "Total operating expenses", "totalLabel": "Total expenses, by nature" } } }, "localname": "OperatingExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherPropertyPlantAndEquipmentMember": { "auth_ref": [ "r46" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing property, plant and equipment that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Other property, plant and equipment [member]", "terseLabel": "Equipment [Member]" } } }, "localname": "OtherPropertyPlantAndEquipmentMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/SignificantAccountingPoliciesDetailTextuals" ], "xbrltype": "domainItemType" }, "ifrs-full_PaymentsForShareIssueCosts": { "auth_ref": [ "r92" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for share issue costs." } }, "en-us": { "role": { "label": "Payments for share issue costs", "negatedLabel": "Share issue expenses" } } }, "localname": "PaymentsForShareIssueCosts", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "auth_ref": [ "r91" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Payments of lease liabilities, classified as financing activities", "negatedLabel": "Lease payments made for discontinued operations" } } }, "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows", "http://predictmedix.com/role/LeasesDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PercentageOfEntitysRevenue": { "auth_ref": [ "r177" ], "lang": { "en": { "role": { "documentation": "The percentage of the entity's revenue. [Refer: Revenue]" } }, "en-us": { "role": { "label": "Percentage of entity's revenue", "terseLabel": "Percentage of revenue" } } }, "localname": "PercentageOfEntitysRevenue", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/BusinessSegmentAndConcentrationDetailTextuals", "http://predictmedix.com/role/FinancialInstrumentsDetailTextuals" ], "xbrltype": "percentItemType" }, "ifrs-full_ProceedsFromExerciseOfOptions": { "auth_ref": [ "r92" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows": { "order": 30.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from the exercise of options." } }, "en-us": { "role": { "label": "Proceeds from exercise of options", "terseLabel": "Proceeds from exercise of options" } } }, "localname": "ProceedsFromExerciseOfOptions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromExerciseOfWarrants": { "auth_ref": [ "r92" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows": { "order": 40.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from the exercise of share purchase warrants." } }, "en-us": { "role": { "label": "Proceeds from exercise of warrants", "terseLabel": "Proceeds from exercise of warrants" } } }, "localname": "ProceedsFromExerciseOfWarrants", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromIssuingOtherEquityInstruments": { "auth_ref": [ "r90" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from issuing equity instruments that the entity does not separately disclose in the same statement or note." } }, "en-us": { "role": { "label": "Proceeds from issuing other equity instruments", "terseLabel": "Proceeds from issuance of units" } } }, "localname": "ProceedsFromIssuingOtherEquityInstruments", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfessionalFeesExpense": { "auth_ref": [ "r8" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 40.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of fees paid or payable for professional services." } }, "en-us": { "role": { "label": "Professional fees expense", "terseLabel": "Consulting fees", "verboseLabel": "Consulting services expenses" } } }, "localname": "ProfessionalFeesExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLoss": { "auth_ref": [ "r3", "r28", "r93", "r102", "r104", "r108", "r169", "r171", "r178", "r183" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 }, "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Profit (loss)", "terseLabel": "Net loss for the year", "totalLabel": "Loss and comprehensive loss", "verboseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity", "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows", "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLossAttributableToAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Profit (loss), attributable to [abstract]", "verboseLabel": "Loss and comprehensive loss attributable to:" } } }, "localname": "ProfitLossAttributableToAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "ifrs-full_ProfitLossAttributableToNoncontrollingInterests": { "auth_ref": [ "r29", "r106" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]" } }, "en-us": { "role": { "label": "Profit (loss), attributable to non-controlling interests", "terseLabel": "Non-controlling interest", "totalLabel": "Non-controlling interest" } } }, "localname": "ProfitLossAttributableToNoncontrollingInterests", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLossAttributableToOwnersOfParent": { "auth_ref": [ "r30" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Profit (loss), attributable to owners of parent", "terseLabel": "Shareholders" } } }, "localname": "ProfitLossAttributableToOwnersOfParent", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLossFromDiscontinuedOperations": { "auth_ref": [ "r33", "r35", "r112", "r149" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows": { "order": 40.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0 }, "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 0.0, "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The profit (loss) from discontinued operations. [Refer: Discontinued operations [member]; Profit (loss)]" } }, "en-us": { "role": { "label": "Profit (loss) from discontinued operations", "negatedLabel": "Loss (income) from discontinues operations", "terseLabel": "Income (loss) from discontinued operations", "verboseLabel": "Income (loss) from discontinued operations, net of tax" } } }, "localname": "ProfitLossFromDiscontinuedOperations", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows", "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PropertyPlantAndEquipment": { "auth_ref": [ "r12", "r52" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 20.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period." } }, "en-us": { "role": { "label": "Property, plant and equipment", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Property and equipment" } } }, "localname": "PropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/BusinessSegmentAndConcentrationDetailTextuals", "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition", "http://predictmedix.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, plant and equipment [abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_PropertyPlantAndEquipmentMember": { "auth_ref": [ "r53", "r73", "r124" ], "lang": { "en": { "role": { "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Property, plant and equipment [member]" } } }, "localname": "PropertyPlantAndEquipmentMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/PropertyAndEquipmentDetails", "http://predictmedix.com/role/SignificantAccountingPoliciesDetailTextuals" ], "xbrltype": "domainItemType" }, "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": { "auth_ref": [ "r66", "r68", "r107" ], "lang": { "en": { "role": { "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Proportion of ownership interest in subsidiary", "terseLabel": "Ownership interest percentage acquired", "verboseLabel": "Ownership interest percentage" } } }, "localname": "ProportionOfOwnershipInterestInSubsidiary", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/BasisOfPresentationAndGoingConcernDetails", "http://predictmedix.com/role/OrganizationAndNatureOfOperationsDetailTextuals", "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedDetailTextuals" ], "xbrltype": "percentItemType" }, "ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests": { "auth_ref": [ "r105" ], "lang": { "en": { "role": { "documentation": "The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Subsidiaries [member]; Non-controlling interests]" } }, "en-us": { "role": { "label": "Proportion of ownership interests held by non-controlling interests", "verboseLabel": "Remaining ownership percentage" } } }, "localname": "ProportionOfOwnershipInterestsHeldByNoncontrollingInterests", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/OrganizationAndNatureOfOperationsDetailTextuals" ], "xbrltype": "percentItemType" }, "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": { "auth_ref": [ "r89" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Purchase of intangible assets, classified as investing activities", "negatedLabel": "Purchase of intangible assets", "negatedTerseLabel": "Purchase of intangible assets", "positiveTerseLabel": "Acquisition", "terseLabel": "Cash consideration on closing", "verboseLabel": "Purchase price in cash" } } }, "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows", "http://predictmedix.com/role/IntangibleAssetsDetailTextuals", "http://predictmedix.com/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "auth_ref": [ "r89" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Purchase of property, plant and equipment, classified as investing activities", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RentalExpense": { "auth_ref": [ "r34" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 140.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense recognised on rental activities." } }, "en-us": { "role": { "label": "Rental expense", "terseLabel": "Rent", "verboseLabel": "Rent expense" } } }, "localname": "RentalExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://predictmedix.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ResearchAndDevelopmentExpense": { "auth_ref": [ "r81" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 70.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss." } }, "en-us": { "role": { "label": "Research and development expense", "terseLabel": "Expenses to conduct a study", "verboseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ReserveOfSharebasedPayments": { "auth_ref": [ "r23" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 10.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "A component of equity resulting from share-based payments." } }, "en-us": { "role": { "label": "Reserve of share-based payments", "terseLabel": "Share-based payment reserve" } } }, "localname": "ReserveOfSharebasedPayments", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ReserveOfSharebasedPaymentsMember": { "auth_ref": [ "r7" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity resulting from share-based payments." } }, "en-us": { "role": { "label": "Reserve of share-based payments [member]", "verboseLabel": "Share-based payment reserve [Member]" } } }, "localname": "ReserveOfSharebasedPaymentsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_RetainedEarnings": { "auth_ref": [ "r23", "r37" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 30.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit." } }, "en-us": { "role": { "label": "Retained earnings", "negatedLabel": "Accumulated deficit", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarnings", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/BasisOfPresentationAndGoingConcernDetails", "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RetainedEarningsMember": { "auth_ref": [ "r6", "r7" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } }, "en-us": { "role": { "label": "Retained earnings [member]", "verboseLabel": "Deficit [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_Revenue": { "auth_ref": [ "r1", "r2", "r31", "r108", "r111", "r150", "r166", "r170", "r175", "r176", "r177" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 0.0, "parentTag": "ifrs-full_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims." } }, "en-us": { "role": { "label": "Revenue", "terseLabel": "Revenue" } } }, "localname": "Revenue", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RightofuseAssets": { "auth_ref": [ "r123" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee." } }, "en-us": { "role": { "label": "Right-of-use assets", "periodEndLabel": "Balance", "periodStartLabel": "Balance" } } }, "localname": "RightofuseAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/LeasesDetailTextuals", "http://predictmedix.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SalesAndMarketingExpense": { "auth_ref": [ "r34" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 130.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense relating to the marketing and selling of goods or services." } }, "en-us": { "role": { "label": "Sales and marketing expense", "terseLabel": "Marketing expenses" } } }, "localname": "SalesAndMarketingExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://predictmedix.com/role/RelatedPartyTransactionsDetailTextuals" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ShareIssueRelatedCost": { "auth_ref": [ "r5" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cost related to the issuance of shares." } }, "en-us": { "role": { "label": "Share issue related cost", "negatedTerseLabel": "Share issuance costs", "terseLabel": "Share issuance costs" } } }, "localname": "ShareIssueRelatedCost", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates": { "auth_ref": [ "r26" ], "lang": { "en": { "role": { "documentation": "The number of shares in the entity held by the entity or by its subsidiaries or associates. [Refer: Associates [member]; Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Number of shares in entity held by entity or by its subsidiaries or associates", "terseLabel": "Number of aggregate common shares issued" } } }, "localname": "SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/OrganizationAndNatureOfOperationsDetailTextuals" ], "xbrltype": "sharesItemType" }, "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": { "auth_ref": [ "r67", "r69", "r116" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Subsidiaries [axis]" } } }, "localname": "SignificantInvestmentsInSubsidiariesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/AcquisitionsDetailTextuals", "http://predictmedix.com/role/AcquisitionsDetails", "http://predictmedix.com/role/BasisOfPresentationAndGoingConcernDetails", "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/OrganizationAndNatureOfOperationsDetailTextuals", "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedDetailTextuals", "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of cash flows [abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_StatementOfChangesInEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [abstract]" } } }, "localname": "StatementOfChangesInEquityAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_StatementOfChangesInEquityLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Statement of changes in equity [line items]" } } }, "localname": "StatementOfChangesInEquityLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "ifrs-full_StatementOfChangesInEquityTable": { "auth_ref": [ "r6" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } }, "en-us": { "role": { "label": "Statement of changes in equity [table]" } } }, "localname": "StatementOfChangesInEquityTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "ifrs-full_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of financial position [abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_SubsidiariesMember": { "auth_ref": [ "r60", "r67", "r69", "r116" ], "lang": { "en": { "role": { "documentation": "This member stands for entities that are controlled by another entity." } }, "en-us": { "role": { "label": "Subsidiaries [member]", "terseLabel": "Cultivar Holdings Ltd. [Member]" } } }, "localname": "SubsidiariesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/AcquisitionsDetailTextuals", "http://predictmedix.com/role/AcquisitionsDetails", "http://predictmedix.com/role/BasisOfPresentationAndGoingConcernDetails", "http://predictmedix.com/role/OrganizationAndNatureOfOperationsDetailTextuals" ], "xbrltype": "domainItemType" }, "ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss": { "auth_ref": [ "r39" ], "calculation": { "http://predictmedix.com/role/IncomeTaxesDetails": { "order": 20.0, "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]" } }, "en-us": { "role": { "label": "Tax effect of expense not deductible in determining taxable profit (tax loss)", "verboseLabel": "Non-deductible items" } } }, "localname": "TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": { "auth_ref": [ "r39" ], "calculation": { "http://predictmedix.com/role/IncomeTaxesDetails": { "order": 0.0, "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]" } }, "en-us": { "role": { "label": "Tax expense (income) at applicable tax rate", "verboseLabel": "Expected income tax recoverable at statutory rate" } } }, "localname": "TaxExpenseIncomeAtApplicableTaxRate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis": { "auth_ref": [ "r43" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Temporary difference, unused tax losses and unused tax credits [axis]" } } }, "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember": { "auth_ref": [ "r43" ], "lang": { "en": { "role": { "documentation": "This member stands for temporary differences, unused tax losses and unused tax credits. It also represents the standard value for the 'Temporary difference, unused tax losses and unused tax credits' axis if no other member is used. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]" } }, "en-us": { "role": { "label": "Temporary difference, unused tax losses and unused tax credits [member]" } } }, "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails2" ], "xbrltype": "domainItemType" }, "ifrs-full_TradeAndOtherCurrentPayables": { "auth_ref": [ "r15" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 10.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]" } }, "en-us": { "role": { "label": "Trade and other current payables", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "TradeAndOtherCurrentPayables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r143" ], "calculation": { "http://predictmedix.com/role/AcquisitionsDetails": { "order": 10.0, "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Business combinations [member]]" } }, "en-us": { "role": { "label": "Trade and other payables recognised as of acquisition date", "negatedLabel": "Accounts payable and accrued liabilities", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "TradeAndOtherPayablesRecognisedAsOfAcquisitionDate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/AcquisitionsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TransportationExpense": { "auth_ref": [ "r8" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 150.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense arising from transportation services." } }, "en-us": { "role": { "label": "Transportation expense", "terseLabel": "Vehicle use expenses" } } }, "localname": "TransportationExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TravelExpense": { "auth_ref": [ "r8" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 60.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense arising from travel." } }, "en-us": { "role": { "label": "Travel expense", "terseLabel": "Travel, entertainment and related" } } }, "localname": "TravelExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TypesOfRisksAxis": { "auth_ref": [ "r154", "r157", "r158", "r179", "r180", "r181", "r182" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Types of risks [axis]" } } }, "localname": "TypesOfRisksAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/BusinessSegmentAndConcentrationDetailTextuals", "http://predictmedix.com/role/FinancialInstrumentsDetailTextuals" ], "xbrltype": "stringItemType" }, "ifrs-full_TypesOfRisksMember": { "auth_ref": [ "r154", "r157", "r158", "r179", "r180", "r181", "r182" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used." } }, "en-us": { "role": { "label": "Risks [member]" } } }, "localname": "TypesOfRisksMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/BusinessSegmentAndConcentrationDetailTextuals", "http://predictmedix.com/role/FinancialInstrumentsDetailTextuals" ], "xbrltype": "domainItemType" }, "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r74" ], "lang": { "en": { "role": { "documentation": "The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Useful life measured as period of time, intangible assets other than goodwill", "verboseLabel": "Estimated useful life intangible assets" } } }, "localname": "UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetailTextuals" ], "xbrltype": "durationItemType" }, "ifrs-full_WagesAndSalaries": { "auth_ref": [ "r57" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 100.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]" } }, "en-us": { "role": { "label": "Wages and salaries", "terseLabel": "Payroll and related" } } }, "localname": "WagesAndSalaries", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_WarrantReserve": { "auth_ref": [ "r23" ], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 20.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "A component of equity resulting from issuing share purchase warrants, other than those resulting from share-based payment arrangements. [Refer: Reserve of share-based payments]" } }, "en-us": { "role": { "label": "Warrant reserve", "terseLabel": "Warrant reserve" } } }, "localname": "WarrantReserve", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_WarrantReserveMember": { "auth_ref": [ "r7" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity resulting from issuing share purchase warrants, other than those resulting from share-based payment arrangements. [Refer: Reserve of share-based payments [member]]" } }, "en-us": { "role": { "label": "Warrant reserve [member]", "verboseLabel": "Warrant reserve [Member]" } } }, "localname": "WarrantReserveMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019": { "auth_ref": [ "r138" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of other equity instruments exercisable in share-based payment arrangement", "terseLabel": "Exercise price of warrants exercisable" } } }, "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r138" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement", "terseLabel": "Weighted average exercise price exercised", "verboseLabel": "Weighted average exercise price of warrants exercised" } } }, "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/CapitalStockDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement2019": { "auth_ref": [ "r138" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) expired in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of other equity instruments expired in share-based payment arrangement", "terseLabel": "Weighted average exercise price expired" } } }, "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r138" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of other equity instruments granted in share-based payment arrangement", "terseLabel": "Weighted average exercise price issued" } } }, "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019": { "auth_ref": [ "r138" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement", "periodEndLabel": "Weighted average exercise price at ending of period", "periodStartLabel": "Weighted average exercise price at beginning of period", "terseLabel": "Exercise Price" } } }, "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetails", "http://predictmedix.com/role/CapitalStockDetails1" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r132" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options exercised in share-based payment arrangement", "terseLabel": "Exercise price of share options exercised", "verboseLabel": "Weighted average exercise price, exercised" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/StockbasedCompensationDetails1" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019": { "auth_ref": [ "r133" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options expired in share-based payment arrangement", "verboseLabel": "Weighted average exercise price, expired" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetails1" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r131" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options granted in share-based payment arrangement", "verboseLabel": "Weighted average exercise price, granted" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetails1" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": { "auth_ref": [ "r130", "r134" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement", "periodEndLabel": "Weighted average exercise price outstanding, end of period", "periodStartLabel": "Weighted average exercise price outstanding, beginning of period" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetails1" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": { "auth_ref": [ "r137" ], "lang": { "en": { "role": { "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average remaining contractual life of outstanding share options", "verboseLabel": "Remaining Life (Years)" } } }, "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetails2" ], "xbrltype": "durationItemType" }, "ifrs-full_WeightedAverageShares": { "auth_ref": [ "r72" ], "lang": { "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } }, "en-us": { "role": { "label": "Weighted average number of ordinary shares used in calculating basic earnings per share", "terseLabel": "Weighted average number of shares outstanding-Basic and Diluted" } } }, "localname": "WeightedAverageShares", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "sharesItemType" }, "pmedf_AdditionalSharesIssuedToAcquireIntangibleAssetsOnNinetiethDayOfClose": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents additional shares issued to acquire intangible assets on ninetieth day of close.", "label": "Additional Shares Issued To Acquire Intangible Assets On Ninetieth Day Of Close", "terseLabel": "Additional shares issued to acquire intangible assets on ninetieth day of close" } } }, "localname": "AdditionalSharesIssuedToAcquireIntangibleAssetsOnNinetiethDayOfClose", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetailTextuals" ], "xbrltype": "sharesItemType" }, "pmedf_AdditionalSharesIssuedToAcquireIntangibleAssetsOnReleaseOfInitialPlatforms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent the additional shares issued to acquire intangible assets on release of initial platforms.", "label": "Additional Shares Issued To Acquire Intangible Assets On Release Of Initial Platforms", "terseLabel": "Additional shares issued to acquire intangible assets on release of initial platforms" } } }, "localname": "AdditionalSharesIssuedToAcquireIntangibleAssetsOnReleaseOfInitialPlatforms", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetailTextuals" ], "xbrltype": "sharesItemType" }, "pmedf_AdditionalSharesTerminated": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents additional shares terminated.", "label": "Additional Shares Terminated", "verboseLabel": "Additional shares terminated" } } }, "localname": "AdditionalSharesTerminated", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedDetailTextuals" ], "xbrltype": "sharesItemType" }, "pmedf_AdjustmentForDecreaseIncreaseInNetAssetsFromDiscontinuedOperations": { "auth_ref": [], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows": { "order": 50.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of decrease increase in net assets from discontinued operations.", "label": "Adjustment For Decrease Increase In Net Assets From Discontinued Operations", "terseLabel": "Net assets from discontinued operations" } } }, "localname": "AdjustmentForDecreaseIncreaseInNetAssetsFromDiscontinuedOperations", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "pmedf_AdjustmentsForDecreaseIncreaseInSalesTaxReceivable": { "auth_ref": [], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustments for decrease (increase) in sales tax receivable to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments For Decrease Increase In Sales Tax Receivable", "terseLabel": "Sales tax receivable" } } }, "localname": "AdjustmentsForDecreaseIncreaseInSalesTaxReceivable", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "pmedf_AdjustmentsForSharesIssuedForConsultingServices": { "auth_ref": [], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the adjustment for shares for consulting services to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments For Shares Issued For Consulting Services", "negatedLabel": "Shares issued for consulting services", "verboseLabel": "Shares issued for consulting services" } } }, "localname": "AdjustmentsForSharesIssuedForConsultingServices", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "pmedf_CanadianSecuritiesExchangeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Canadian Securities Exchange.", "label": "Canadian Securities Exchange [Member]" } } }, "localname": "CanadianSecuritiesExchangeMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "pmedf_ComponentsOfDeferredTaxAssetsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components Of Deferred Tax Assets [Axis]" } } }, "localname": "ComponentsOfDeferredTaxAssetsAxis", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails1" ], "xbrltype": "stringItemType" }, "pmedf_ComponentsOfDeferredTaxAssetsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components Of Deferred Tax Assets [Domain]" } } }, "localname": "ComponentsOfDeferredTaxAssetsDomain", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails1" ], "xbrltype": "domainItemType" }, "pmedf_ConsiderationFromSharesIssued": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represent the amount of consideration from shares issued.", "label": "Consideration From Shares Issued", "terseLabel": "Consideration from shares issued" } } }, "localname": "ConsiderationFromSharesIssued", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "monetaryItemType" }, "pmedf_ConsiderationFromSharesIssuedExpensedToConsultingServices": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represent the consideration from shares issued expensed to consulting services.", "label": "Consideration from shares issued expensed to consulting services" } } }, "localname": "ConsiderationFromSharesIssuedExpensedToConsultingServices", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "monetaryItemType" }, "pmedf_ConsiderationFromSharesIssuedIncludedInPrepaidExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represent the consideration from shares issued included in prepaid expenses.", "label": "Consideration from shares issued included in prepaid expenses" } } }, "localname": "ConsiderationFromSharesIssuedIncludedInPrepaidExpenses", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "monetaryItemType" }, "pmedf_ConsiderationOfIntangibleAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consideration Of Intangible Assets [Abstract]", "verboseLabel": "Consideration" } } }, "localname": "ConsiderationOfIntangibleAssetsAbstract", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "pmedf_ConsiderationTransferredForAcquisitionOfIntangibleAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of consideration transferred for acquisition of intangible assets.", "label": "Consideration transferred for acquisition of intangible assets", "terseLabel": "Total Consideration" } } }, "localname": "ConsiderationTransferredForAcquisitionOfIntangibleAssets", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetailTextuals", "http://predictmedix.com/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "pmedf_ConsultantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for a consultant.", "label": "Consultant [Member]", "verboseLabel": "Consultant [Member]" } } }, "localname": "ConsultantMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals", "http://predictmedix.com/role/StockbasedCompensationDetails", "http://predictmedix.com/role/StockbasedCompensationTables" ], "xbrltype": "domainItemType" }, "pmedf_DeductibleTemporaryDifferencesExpiry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents deductible temporary difference in expiry.", "label": "Deductible Temporary Differences Expiry", "verboseLabel": "Temporary differences, expiry period" } } }, "localname": "DeductibleTemporaryDifferencesExpiry", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails2" ], "xbrltype": "stringItemType" }, "pmedf_DescriptionOfAccountingPolicyForNewStandardsNotYetAdoptedExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The description of the entity's accounting policy for new standards not yet adopted.", "label": "Description Of Accounting Policy For New Standards Not Yet Adopted Explanatory", "terseLabel": "New standards not yet adopted [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForNewStandardsNotYetAdoptedExplanatory", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "pmedf_DescriptionOfExpectedForfeitureRateShareOptionsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of an expected forfeiture rate used to calculate the fair value of share options granted.", "label": "Description Of Expected Forfeiture Rate Share Options Granted", "verboseLabel": "Expected forfeiture rate" } } }, "localname": "DescriptionOfExpectedForfeitureRateShareOptionsGranted", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetails" ], "xbrltype": "percentItemType" }, "pmedf_DirectorsOfficersAndConsultantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for a directors, officers and consultants.", "label": "Directors, Officers And Consultants [Member]", "verboseLabel": "Directors, officers and consultants [Member]" } } }, "localname": "DirectorsOfficersAndConsultantsMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals", "http://predictmedix.com/role/StockbasedCompensationDetails", "http://predictmedix.com/role/StockbasedCompensationTables" ], "xbrltype": "domainItemType" }, "pmedf_DisclosureOfAssetsAcquiredAsOfAcquisitionDateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Assets Acquired As Of Acquisition Date [Abstract]", "terseLabel": "Assets acquired by the Company:" } } }, "localname": "DisclosureOfAssetsAcquiredAsOfAcquisitionDateAbstract", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/AcquisitionsDetails" ], "xbrltype": "stringItemType" }, "pmedf_DisclosureOfBasisOfPresentationAndGoingConcernAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Disclosure Of Basis Of Presentation And Going Concern [Abstract]" } } }, "localname": "DisclosureOfBasisOfPresentationAndGoingConcernAbstract", "nsuri": "http://predictmedix.com/20220131", "xbrltype": "stringItemType" }, "pmedf_DisclosureOfBasisOfPresentationAndGoingConcernExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information of disclosure of basis of presentation and going concern.", "label": "Disclosure Of Basis Of Presentation And Going Concern Explanatory", "terseLabel": "Basis of Presentation and Going Concern [Text Block]" } } }, "localname": "DisclosureOfBasisOfPresentationAndGoingConcernExplanatory", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/BasisOfPresentationAndGoingConcern" ], "xbrltype": "textBlockItemType" }, "pmedf_DisclosureOfBasisOfPresentationAndGoingConcernLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.", "label": "Disclosure Of Basis Of Presentation And Going Concern [Line Items]" } } }, "localname": "DisclosureOfBasisOfPresentationAndGoingConcernLineItems", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/BasisOfPresentationAndGoingConcernDetails" ], "xbrltype": "stringItemType" }, "pmedf_DisclosureOfBasisOfPresentationAndGoingConcernTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule disclosing information related to basis of presentation and going concern.", "label": "Disclosure Of Basis Of Presentation And Going Concern [Table]" } } }, "localname": "DisclosureOfBasisOfPresentationAndGoingConcernTable", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/BasisOfPresentationAndGoingConcernDetails" ], "xbrltype": "stringItemType" }, "pmedf_DisclosureOfCapitalManagementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Capital Management [Abstract]", "terseLabel": "Capital Management" } } }, "localname": "DisclosureOfCapitalManagementAbstract", "nsuri": "http://predictmedix.com/20220131", "xbrltype": "stringItemType" }, "pmedf_DisclosureOfCommitmentsAndContingenciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Commitments And Contingencies [Abstract]" } } }, "localname": "DisclosureOfCommitmentsAndContingenciesAbstract", "nsuri": "http://predictmedix.com/20220131", "xbrltype": "stringItemType" }, "pmedf_DisclosureOfDetailedInformationAboutLeaseLiabilityExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about lease liability.", "label": "Disclosure Of Detailed Information About Lease Liability Explanatory", "terseLabel": "Disclosure of lease liability [Table Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutLeaseLiabilityExplanatory", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "pmedf_DisclosureOfDetailedInformationAboutNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about the net loss and comprehensive loss from discontinued operations.", "label": "Disclosure Of Detailed Information About Net Loss And Comprehensive Loss From Discontinued Operations Explanatory", "terseLabel": "Disclosure of income (loss) and comprehensive income (loss) from discontinued operations [Table Text Block]", "verboseLabel": "Disclosure of Income (loss) from discontinued operations [Table Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedTables" ], "xbrltype": "textBlockItemType" }, "pmedf_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about valuation assumptions for options.", "label": "Disclosure Of Detailed Information About Options, Valuation Assumptions Explanatory", "verboseLabel": "Disclosure of detailed information about options, valuation assumptions [Table Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "pmedf_DisclosureOfDetailedInformationAboutPurchasePriceAllocationOfIntangibleAssetsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about purchase price allocation of intangible assets.", "label": "Disclosure Of Detailed Information About Purchase Price Allocation Of Intangible Assets Explanatory", "terseLabel": "Disclosure of detailed information about purchase price allocation of intangible assets [Table Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutPurchasePriceAllocationOfIntangibleAssetsExplanatory", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "pmedf_DisclosureOfDetailedInformationAboutRecognizeLiabilityWhenRelatedActivityGivesRiseToVariabilityOccursExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about recognize liability when related activity gives rise to variability occurs.", "label": "Disclosure Of Detailed Information About Recognize Liability When Related Activity Gives Rise To Variability Occurs Explanatory", "verboseLabel": "Disclosure of detailed information about recognize liability when related activity gives rise to variability occurs [Table Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutRecognizeLiabilityWhenRelatedActivityGivesRiseToVariabilityOccursExplanatory", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "pmedf_DisclosureOfDetailedInformationAboutReconciliationOfProvisionForIncomeTaxesExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about reconciliation of provision for income taxes.", "label": "Disclosure Of Detailed Information About Reconciliation Of Provision For Income Taxes Explanatory", "verboseLabel": "Disclosure of reconciliation of provision for income taxes [Table Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutReconciliationOfProvisionForIncomeTaxesExplanatory", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "pmedf_DisclosureOfDetailedInformationAboutUnrecognizedTemporaryDifferencesAndTaxLossesExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about unrecognized temporary differences and tax losses.", "label": "Disclosure Of Detailed Information About Unrecognized Temporary Differences And Tax Losses Explanatory", "verboseLabel": "Disclosure of unrecognized temporary differences and tax losses [Table Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutUnrecognizedTemporaryDifferencesAndTaxLossesExplanatory", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "pmedf_DisclosureOfInformationAboutIncomeTaxesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.", "label": "Disclosure Of Information About Income Taxes [Line Items]" } } }, "localname": "DisclosureOfInformationAboutIncomeTaxesLineItems", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails1" ], "xbrltype": "stringItemType" }, "pmedf_DisclosureOfInformationAboutIncomeTaxesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Information About Income Taxes [Table]" } } }, "localname": "DisclosureOfInformationAboutIncomeTaxesTable", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails1" ], "xbrltype": "stringItemType" }, "pmedf_DisclosureOfLiabilitiesAssumedAsOfAcquisitionDateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Liabilities Assumed As Of Acquisition Date [Abstract]", "terseLabel": "Liabilities assumed by the Company:" } } }, "localname": "DisclosureOfLiabilitiesAssumedAsOfAcquisitionDateAbstract", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/AcquisitionsDetails" ], "xbrltype": "stringItemType" }, "pmedf_DisclosureOfNumberExercisePriceAndRemainingContractualLifeOfOutstandingWarrantsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of the number, exercise price and weighted average remaining contractual life of outstanding warrants.", "label": "Disclosure Of Number Exercise Price And Remaining Contractual Life Of Outstanding Warrants Explanatory", "terseLabel": "Disclosure of number, exercise price and remaining life of outstanding warrants [Table Text block]" } } }, "localname": "DisclosureOfNumberExercisePriceAndRemainingContractualLifeOfOutstandingWarrantsExplanatory", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockTables" ], "xbrltype": "textBlockItemType" }, "pmedf_DisclosureOfOrganizationAndNatureOfOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Organization And Nature Of Operations [Abstract]" } } }, "localname": "DisclosureOfOrganizationAndNatureOfOperationsAbstract", "nsuri": "http://predictmedix.com/20220131", "xbrltype": "stringItemType" }, "pmedf_DisclosureOfOrganizationAndNatureOfOperationsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of organization and nature of operations.", "label": "Disclosure Of Organization And Nature Of Operations Explanatory", "terseLabel": "Organization and Nature of Operations [Text Block]" } } }, "localname": "DisclosureOfOrganizationAndNatureOfOperationsExplanatory", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/OrganizationAndNatureOfOperations" ], "xbrltype": "textBlockItemType" }, "pmedf_DisclosureOfPrepaidExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Prepaid Expenses [Abstract]" } } }, "localname": "DisclosureOfPrepaidExpensesAbstract", "nsuri": "http://predictmedix.com/20220131", "xbrltype": "stringItemType" }, "pmedf_DisclosureOfPrepaidExpensesExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for prepaid expenses.", "label": "Disclosure Of Prepaid Expenses Explanatory", "terseLabel": "Prepaid Expenses [Text Block]" } } }, "localname": "DisclosureOfPrepaidExpensesExplanatory", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/PrepaidExpenses" ], "xbrltype": "textBlockItemType" }, "pmedf_DisclosureOfSaleOfInterestInCultivarJaLimitedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "n/a.", "label": "Disclosure Of Sale Of Interest In Cultivar Ja Limited [Abstract]" } } }, "localname": "DisclosureOfSaleOfInterestInCultivarJaLimitedAbstract", "nsuri": "http://predictmedix.com/20220131", "xbrltype": "stringItemType" }, "pmedf_DisclosureOfSaleOfInterestInCultivarJaLimitedLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.", "label": "Disclosure Of Sale Of Interest In Cultivar Ja Limited [Line Items]" } } }, "localname": "DisclosureOfSaleOfInterestInCultivarJaLimitedLineItems", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedDetails" ], "xbrltype": "stringItemType" }, "pmedf_DisclosureOfSaleOfInterestInCultivarJaLimitedTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule disclosing information related to sale of interest in Cultivar JA Limited.", "label": "Disclosure Of Sale Of Interest In Cultivar Ja Limited [Table]" } } }, "localname": "DisclosureOfSaleOfInterestInCultivarJaLimitedTable", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedDetails" ], "xbrltype": "stringItemType" }, "pmedf_DisclosureOfShareBasedCompensationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Share Based Compensation [Abstract]" } } }, "localname": "DisclosureOfShareBasedCompensationAbstract", "nsuri": "http://predictmedix.com/20220131", "xbrltype": "stringItemType" }, "pmedf_DisclosureOfSignificantAccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Significant Accounting Policies [Abstract]" } } }, "localname": "DisclosureOfSignificantAccountingPoliciesAbstract", "nsuri": "http://predictmedix.com/20220131", "xbrltype": "stringItemType" }, "pmedf_DiscontinuanceOfBusinessLeases": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of discontinuance of business, leases.", "label": "Discontinuance Of Business Leases", "negatedNetLabel": "Discontinuance of business" } } }, "localname": "DiscontinuanceOfBusinessLeases", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/LeasesDetails1" ], "xbrltype": "monetaryItemType" }, "pmedf_DiscontinuanceOfBusinessRightOfUseAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of discontinuance of business, right-of-use-assets.", "label": "Discontinuance Of Business Right Of Use Assets", "negatedLabel": "Discontinuance of business", "terseLabel": "Discontinuance of business" } } }, "localname": "DiscontinuanceOfBusinessRightOfUseAssets", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "pmedf_ExpectedDividendYieldOfWarrantsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expected dividend yield of warrants granted.", "label": "Expected Dividend Yield Of Warrants Granted", "terseLabel": "Expected dividend yield of warrants granted" } } }, "localname": "ExpectedDividendYieldOfWarrantsGranted", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "percentItemType" }, "pmedf_ExpectedLifeOfWarrantsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expected life of warrants granted.", "label": "Expected Life Of Warrants Granted", "terseLabel": "Expected life of warrants granted" } } }, "localname": "ExpectedLifeOfWarrantsGranted", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "durationItemType" }, "pmedf_ExpectedVolatilityOfWarransGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expected volatility of warrans granted.", "label": "Expected Volatility Of Warrans Granted", "terseLabel": "Expected volatility of warrans granted" } } }, "localname": "ExpectedVolatilityOfWarransGranted", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "percentItemType" }, "pmedf_ExpireDecemberNineTwoZeroTwoTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expire December 9, 2022.", "label": "Expire December Nine Two Zero Two Two [Member]", "verboseLabel": "December 9, 2022 [Member]" } } }, "localname": "ExpireDecemberNineTwoZeroTwoTwoMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetails2" ], "xbrltype": "domainItemType" }, "pmedf_ExpireJulyOneSevenTwoZeroTwoFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expire July 17, 2025.", "label": "Expire July One Seven Two Zero Two Five [Member]", "verboseLabel": "July 17, 2025 [Member]" } } }, "localname": "ExpireJulyOneSevenTwoZeroTwoFiveMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetails2" ], "xbrltype": "domainItemType" }, "pmedf_ExpireJulyThreeZeroTwoZeroTwoThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expire July 30, 2023.", "label": "Expire July Three Zero Two Zero Two Three [Member]", "verboseLabel": "July 30, 2023 [Member]" } } }, "localname": "ExpireJulyThreeZeroTwoZeroTwoThreeMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetails2" ], "xbrltype": "domainItemType" }, "pmedf_ExpireMarchOneZeroTwoZeroTwoTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expire March 10, 2022.", "label": "Expire March One Zero Two Zero Two Two [Member]", "verboseLabel": "March 10, 2022 [Member]" } } }, "localname": "ExpireMarchOneZeroTwoZeroTwoTwoMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetails2" ], "xbrltype": "domainItemType" }, "pmedf_ExpireMarchThreeZeroTwoZeroTwoTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expire March 30, 2022.", "label": "Expire March Three Zero Two Zero Two Two [Member]", "verboseLabel": "March 30, 2022 [Member]" } } }, "localname": "ExpireMarchThreeZeroTwoZeroTwoTwoMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetails2" ], "xbrltype": "domainItemType" }, "pmedf_ExpireMarchTwoThreeTwoZeroTwoTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expire March 23, 2022.", "label": "Expire March Two Three Two Zero Two Two [Member]", "verboseLabel": "March 23, 2022 [Member]" } } }, "localname": "ExpireMarchTwoThreeTwoZeroTwoTwoMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetails2" ], "xbrltype": "domainItemType" }, "pmedf_ExpiryDateOfOutstandingShareOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents expiry date of outstanding share options.", "label": "Expiry Date Of Outstanding Share Options", "verboseLabel": "Expiry Date" } } }, "localname": "ExpiryDateOfOutstandingShareOptions", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetails2" ], "xbrltype": "stringItemType" }, "pmedf_ExpiryDateOfOutstandingWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiry date of outstanding warrants.", "label": "Expiry Date Of Outstanding Warrants", "terseLabel": "Expiry Date" } } }, "localname": "ExpiryDateOfOutstandingWarrants", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetails1" ], "xbrltype": "dateItemType" }, "pmedf_FairValueOfCommonSharesIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of the common shares issued.", "label": "Fair Value Of Common Shares Issued", "terseLabel": "Fair value of common shares issued" } } }, "localname": "FairValueOfCommonSharesIssued", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "monetaryItemType" }, "pmedf_FairValueOfSharesIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of shares issued for services.", "label": "Fair Value Of Shares Issued For Services", "terseLabel": "Fair value of shares issued for services" } } }, "localname": "FairValueOfSharesIssuedForServices", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "monetaryItemType" }, "pmedf_FairValueOfWarrantsIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of the warrants issued.", "label": "Fair Value Of Warrants Issued", "terseLabel": "Fair value of warrants issued" } } }, "localname": "FairValueOfWarrantsIssued", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "monetaryItemType" }, "pmedf_GainLossOnAcquisition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents about gain (loss) on acquisition.", "label": "Gain (Loss) On Acquisition", "negatedTotalLabel": "Loss on acquisition", "terseLabel": "Loss on acquisition", "totalLabel": "Loss on acquisition" } } }, "localname": "GainLossOnAcquisition", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/AcquisitionsDetails" ], "xbrltype": "monetaryItemType" }, "pmedf_IncreaseDecreaseThroughAcquisitionOfIntangibleAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in equity resulting from the acquisition of intangible assets.", "label": "Increase Decrease Through Acquisition Of Intangible Assets", "terseLabel": "Shares issued on acquisition of intangible asset" } } }, "localname": "IncreaseDecreaseThroughAcquisitionOfIntangibleAssets", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "pmedf_IncreaseDecreaseThroughAcquisitionOfIntangibleAssetsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in equity resulting from the acquisition of intangible asset.", "label": "Increase Decrease Through Acquisition Of Intangible Assets Shares", "terseLabel": "Shares issued on acquisition of intangible asset (Shares)" } } }, "localname": "IncreaseDecreaseThroughAcquisitionOfIntangibleAssetsShares", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "pmedf_IncreaseDecreaseThroughDisposalOfSubsidiaryShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the increase decrease in equity resulting from sale of shares of subsidiary .", "label": "Increase Decrease Through Disposal Of Subsidiary Shares", "negatedLabel": "Sale of Cultivar Jamaica (Shares)", "terseLabel": "Sale of Cultivar Jamaica (Shares)" } } }, "localname": "IncreaseDecreaseThroughDisposalOfSubsidiaryShares", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity", "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedDetailTextuals" ], "xbrltype": "sharesItemType" }, "pmedf_IncreaseDecreaseThroughExerciseOfOptionsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in equity resulting from the exercise of options.", "label": "Increase Decrease Through Exercise Of Options Shares", "terseLabel": "Exercise of options (Shares)" } } }, "localname": "IncreaseDecreaseThroughExerciseOfOptionsShares", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "pmedf_IncreaseDecreaseThroughExerciseOfWarrantsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in equity resulting from the exercise of warrants.", "label": "Increase Decrease Through Exercise Of Warrants Shares", "terseLabel": "Exercise of warrants (Shares)" } } }, "localname": "IncreaseDecreaseThroughExerciseOfWarrantsShares", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "pmedf_IncreaseDecreaseThroughPrivatePlacementOfUnits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase decrease in equity resulting through issuance of shares through private placement.", "label": "Increase Decrease Through Private Placement Of Units", "terseLabel": "Private placement of units" } } }, "localname": "IncreaseDecreaseThroughPrivatePlacementOfUnits", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "pmedf_IncreaseDecreaseThroughPrivatePlacementOfUnitsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The increase decrease in equity resulting through issuance of shares through private placement.", "label": "Increase Decrease Through Private Placement Of Units Shares", "terseLabel": "Private placement of units (Shares)" } } }, "localname": "IncreaseDecreaseThroughPrivatePlacementOfUnitsShares", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "pmedf_IncreaseDecreaseThroughSharesIssuedForConsultingServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the number of shares issued for consulting services.", "label": "Increase Decrease Through Shares Issued For Consulting Services", "terseLabel": "Shares issued for consulting services" } } }, "localname": "IncreaseDecreaseThroughSharesIssuedForConsultingServices", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "pmedf_IncreaseDecreaseThroughSharesIssuedForConsultingServicesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of shares issued for consulting services.", "label": "Increase Decrease Through Shares Issued For Consulting Services Shares", "terseLabel": "Shares issued for consulting services (Shares)" } } }, "localname": "IncreaseDecreaseThroughSharesIssuedForConsultingServicesShares", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/ConsolidatedStatementOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "pmedf_InfectiousDiseaseSymptomScreeningSolutionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for infectious disease symptom screening solution.", "label": "Infectious Disease Symptom Screening Solution [Member]", "terseLabel": "IDSS [Member]", "verboseLabel": "infectious disease symptom screening solution (\"IDSS\") [Member]" } } }, "localname": "InfectiousDiseaseSymptomScreeningSolutionMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetails1" ], "xbrltype": "domainItemType" }, "pmedf_InvestorRelations": { "auth_ref": [], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 10.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of investor relations expense.", "label": "Investor Relations", "terseLabel": "Investor relations" } } }, "localname": "InvestorRelations", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "pmedf_LegalFees": { "auth_ref": [], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 20.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of legal fees.", "label": "Legal Fees", "terseLabel": "Legal fees" } } }, "localname": "LegalFees", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "pmedf_ManagementFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of management fees to key management personnel.", "label": "Management Fees", "terseLabel": "Management fees" } } }, "localname": "ManagementFees", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "pmedf_MobilewellbeingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for MobileWellbeing .", "label": "Mobilewellbeing [Member]", "terseLabel": "MWB [Member]", "verboseLabel": "MobileWellbeing (\"MWB\") [Member]" } } }, "localname": "MobilewellbeingMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/IntangibleAssetsDetailTextuals", "http://predictmedix.com/role/IntangibleAssetsDetails", "http://predictmedix.com/role/IntangibleAssetsDetails1" ], "xbrltype": "domainItemType" }, "pmedf_MonthlyCompensation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represent the amount of monthly compensation.", "label": "Monthly Compensation", "terseLabel": "Monthly compensation" } } }, "localname": "MonthlyCompensation", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CommitmentsAndContingenciesDetailTextuals" ], "xbrltype": "monetaryItemType" }, "pmedf_MonthlyRentObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Information about amount of monthly rent obligation.", "label": "Monthly Rent Obligation", "terseLabel": "Monthly rent obligation" } } }, "localname": "MonthlyRentObligation", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CommitmentsAndContingenciesDetailTextuals" ], "xbrltype": "monetaryItemType" }, "pmedf_NonCapitalLossesAvailableForFuturePeriodMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Non-capital losses available for future period.", "label": "Non Capital Losses Available For Future Period [Member]", "terseLabel": "Non-capital losses", "verboseLabel": "Non-capital losses available for future period [Member]" } } }, "localname": "NonCapitalLossesAvailableForFuturePeriodMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails1", "http://predictmedix.com/role/IncomeTaxesDetails2" ], "xbrltype": "domainItemType" }, "pmedf_NonCashTransactionsDuringTheYearAffectingCashFlowsFromFinancingAndInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non Cash Transactions During The Year Affecting Cash Flows From Financing And Investing Activities [Abstract]", "verboseLabel": "Non-cash transactions during the year affecting cash flows from financing and investing activities:" } } }, "localname": "NonCashTransactionsDuringTheYearAffectingCashFlowsFromFinancingAndInvestingActivitiesAbstract", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "pmedf_NumberOfCommonSharesCancelled": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of common shares cancelled.", "label": "Number Of Common Shares Cancelled", "terseLabel": "Number of common shares cancelled" } } }, "localname": "NumberOfCommonSharesCancelled", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "sharesItemType" }, "pmedf_NumberOfUnitsIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of units issued.", "label": "Number Of Units Issued", "terseLabel": "Number of units issued" } } }, "localname": "NumberOfUnitsIssued", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "sharesItemType" }, "pmedf_OneCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for one customer.", "label": "One Customer [Member]", "verboseLabel": "One customer [Member]" } } }, "localname": "OneCustomerMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/BusinessSegmentAndConcentrationDetailTextuals", "http://predictmedix.com/role/FinancialInstrumentsDetailTextuals" ], "xbrltype": "domainItemType" }, "pmedf_OptionExerciseAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table.", "label": "Option Exercise [Axis]" } } }, "localname": "OptionExerciseAxis", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "stringItemType" }, "pmedf_OptionExerciseDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for option exercise.", "label": "Option Exercise [Domain]" } } }, "localname": "OptionExerciseDomain", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "domainItemType" }, "pmedf_OptionExerciseOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for option exercise one.", "label": "Option Exercise One [Member]" } } }, "localname": "OptionExerciseOneMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "domainItemType" }, "pmedf_OptionExerciseTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for option exercise two.", "label": "Option Exercise Two [Member]" } } }, "localname": "OptionExerciseTwoMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "domainItemType" }, "pmedf_OptionsAuthorizedUnderStockOptionPlanAsPercentageOfIssuedAndOutstandingCommonShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Options authorized under stock option plan as a percentage of issued and outstanding common shares.", "label": "Options Authorized Under Stock Option Plan As Percentage Of Issued And Outstanding Common Shares", "verboseLabel": "Options authorized under stock option plan as a percentage of issued and outstanding common shares" } } }, "localname": "OptionsAuthorizedUnderStockOptionPlanAsPercentageOfIssuedAndOutstandingCommonShares", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals" ], "xbrltype": "percentItemType" }, "pmedf_OptionsOutstandingByExpirationDateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Options outstanding by expiration date.", "label": "Options Outstanding By Expiration Date [Axis]" } } }, "localname": "OptionsOutstandingByExpirationDateAxis", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetails2" ], "xbrltype": "stringItemType" }, "pmedf_OptionsOutstandingByExpirationDateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Options outstanding by expiration date.", "label": "Options Outstanding By Expiration Date [Domain]" } } }, "localname": "OptionsOutstandingByExpirationDateDomain", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetails2" ], "xbrltype": "domainItemType" }, "pmedf_PatentAndTrademarkExpenses": { "auth_ref": [], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 50.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of patent and trademark expenses.", "label": "Patent And Trademark Expenses", "terseLabel": "Patent and trademark expenses" } } }, "localname": "PatentAndTrademarkExpenses", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "pmedf_PercentageOfAccountsReceivable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of the accounts receivable.", "label": "Percentage Of Accounts Receivable", "terseLabel": "Percentage of accounts receivable" } } }, "localname": "PercentageOfAccountsReceivable", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/BusinessSegmentAndConcentrationDetailTextuals", "http://predictmedix.com/role/FinancialInstrumentsDetailTextuals" ], "xbrltype": "percentItemType" }, "pmedf_PercentageOfRoyaltyOfGrossSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents percentage of royalty of gross sales.", "label": "Percentage Of Royalty Of Gross Sales", "verboseLabel": "Percentage of royalty of gross sales" } } }, "localname": "PercentageOfRoyaltyOfGrossSales", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetailTextuals" ], "xbrltype": "percentItemType" }, "pmedf_PersonalVehicleObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of amount of personal vehicle obligation.", "label": "Personal Vehicle Obligation", "terseLabel": "Personal vehicle obligation" } } }, "localname": "PersonalVehicleObligation", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CommitmentsAndContingenciesDetailTextuals" ], "xbrltype": "monetaryItemType" }, "pmedf_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement.", "label": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "domainItemType" }, "pmedf_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the profit (loss) before other income and gain (loss) on sale of equipment from discontinued operations.", "label": "Profit Loss Before Other Income And Gain Loss On Sale Of Equipment From Discontinued Operations", "terseLabel": "Net loss for the period prior to the sale transaction" } } }, "localname": "ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedDetails" ], "xbrltype": "monetaryItemType" }, "pmedf_PropertyEquipmentAndIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for property equipment and intangible assets.", "label": "Property Equipment And Intangible Assets [Member]", "verboseLabel": "Property equipment and intangible assets [Member]" } } }, "localname": "PropertyEquipmentAndIntangibleAssetsMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails1", "http://predictmedix.com/role/IncomeTaxesDetails2" ], "xbrltype": "domainItemType" }, "pmedf_PurchasePriceAllocationOfIntangibleAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "It represents purchase price allocation of intangible assets.", "label": "Purchase Price Allocation Of Intangible Assets", "verboseLabel": "Total Purchase Price allocation" } } }, "localname": "PurchasePriceAllocationOfIntangibleAssets", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "pmedf_PurchasePriceAllocationOfIntangibleAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Purchase Price Allocation Of Intangible Assets [Abstract]", "verboseLabel": "Purchase Price allocation" } } }, "localname": "PurchasePriceAllocationOfIntangibleAssetsAbstract", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "pmedf_RevisedMonthlyCompensation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Information about revised monthly compensation.", "label": "Revised Monthly Compensation", "terseLabel": "Revised monthly compensation" } } }, "localname": "RevisedMonthlyCompensation", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CommitmentsAndContingenciesDetailTextuals" ], "xbrltype": "monetaryItemType" }, "pmedf_RiskFreeInterestRateWarrantsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Risk free interest rate, warrants granted.", "label": "Risk Free Interest Rate Warrants Granted", "terseLabel": "Risk free interest rate, warrants granted" } } }, "localname": "RiskFreeInterestRateWarrantsGranted", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "percentItemType" }, "pmedf_SaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of stock.", "label": "Sale Of Stock [Axis]" } } }, "localname": "SaleOfStockAxis", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "stringItemType" }, "pmedf_SaleOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of stock.", "label": "Sale Of Stock [Domain]" } } }, "localname": "SaleOfStockDomain", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "domainItemType" }, "pmedf_SalesApplicableToRoyalty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represent the amount of sales applicable to royalty.", "label": "Sales Applicable To Royalty", "terseLabel": "Sales applicable to royalty", "verboseLabel": "Amount of royalty payment from sales generated" } } }, "localname": "SalesApplicableToRoyalty", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetailTextuals" ], "xbrltype": "monetaryItemType" }, "pmedf_ShareBasedPaymentArrangementVestingTrancheFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fourth portion of options under share-based payment arrangement differentiated by vesting features.", "label": "Share Based Payment Arrangement, Vesting Tranche Four [Member]", "verboseLabel": "Vesting Tranche Four [Member]" } } }, "localname": "ShareBasedPaymentArrangementVestingTrancheFourMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals" ], "xbrltype": "domainItemType" }, "pmedf_ShareBasedPaymentArrangementVestingTrancheOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First portion of options under share-based payment arrangement differentiated by vesting features.", "label": "Share Based Payment Arrangement, Vesting Tranche One [Member]", "verboseLabel": "Vesting Tranche One [Member]" } } }, "localname": "ShareBasedPaymentArrangementVestingTrancheOneMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals" ], "xbrltype": "domainItemType" }, "pmedf_ShareBasedPaymentArrangementVestingTrancheThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third portion of options under share-based payment arrangement differentiated by vesting features.", "label": "Share Based Payment Arrangement, Vesting Tranche Three [Member]", "verboseLabel": "Vesting Tranche Three [Member]" } } }, "localname": "ShareBasedPaymentArrangementVestingTrancheThreeMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals" ], "xbrltype": "domainItemType" }, "pmedf_ShareBasedPaymentArrangementVestingTrancheThreeOnCompletionOfAdditionalMilestonesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third portion of options under share-based payment arrangement differentiated by vesting features on completion of additional milestones.", "label": "Share Based Payment Arrangement, Vesting Tranche Three On Completion Of Additional Milestones [Member]", "verboseLabel": "Vesting Tranche Three, on model development [Member]" } } }, "localname": "ShareBasedPaymentArrangementVestingTrancheThreeOnCompletionOfAdditionalMilestonesMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals" ], "xbrltype": "domainItemType" }, "pmedf_ShareBasedPaymentArrangementVestingTrancheThreeOnExpiryTermMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third portion of options under share-based payment arrangement differentiated by vesting features on expiry term of the options.", "label": "Share Based Payment Arrangement, Vesting Tranche Three On Expiry Term [Member]", "verboseLabel": "Vesting Tranche Three, on project handover [Member]" } } }, "localname": "ShareBasedPaymentArrangementVestingTrancheThreeOnExpiryTermMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals" ], "xbrltype": "domainItemType" }, "pmedf_ShareBasedPaymentArrangementVestingTrancheTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second portion of options under share-based payment arrangement differentiated by vesting features.", "label": "Share Based Payment Arrangement, Vesting Tranche Two [Member]", "verboseLabel": "Vesting Tranche Two [Member]" } } }, "localname": "ShareBasedPaymentArrangementVestingTrancheTwoMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals" ], "xbrltype": "domainItemType" }, "pmedf_ShareIssuanceCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member .stands for Share issuance costs", "label": "Share Issuance Costs [Member]", "verboseLabel": "Share issuance costs [Member]" } } }, "localname": "ShareIssuanceCostsMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails1", "http://predictmedix.com/role/IncomeTaxesDetails2" ], "xbrltype": "domainItemType" }, "pmedf_SharesIssuedForAcquisitionOfIntangibleAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of shares issued for acquisition of intangible assets.", "label": "Shares Issued For Acquisition Of Intangible Assets", "verboseLabel": "Shares issued for acquisition of intangible assets" } } }, "localname": "SharesIssuedForAcquisitionOfIntangibleAssets", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "pmedf_SharesIssuedForPrepaymentAndExpenseForConsultingFees": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of share issue for prepayment and expense for consulting fees.", "label": "Shares Issued For Prepayment And Expense For Consulting Fees", "terseLabel": "Shares issued for prepayment and expense for consulting fees" } } }, "localname": "SharesIssuedForPrepaymentAndExpenseForConsultingFees", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "pmedf_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the share issued price per share.", "label": "Shares Issued Price Per Share", "terseLabel": "Shares issued, price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "perShareItemType" }, "pmedf_SharesIssuedPricePerShareAsOfAcquisitionDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents about shares issued price per share as of acquisition date.", "label": "Shares Issued Price Per Share As Of Acquisition Date", "terseLabel": "Shares issued, price per share" } } }, "localname": "SharesIssuedPricePerShareAsOfAcquisitionDate", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/AcquisitionsDetailTextuals" ], "xbrltype": "perShareItemType" }, "pmedf_SharesIssuedToAcquireIntangibleAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued by the entity.", "label": "Shares issued to acquire intangible assets" } } }, "localname": "SharesIssuedToAcquireIntangibleAssets", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetailTextuals" ], "xbrltype": "sharesItemType" }, "pmedf_SharesIssuedToAcquireIntangibleAssetsIncludingClosing": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent the shares issued to acquire intangible assets, including closing.", "label": "Shares issued to acquire intangible assets, including closing" } } }, "localname": "SharesIssuedToAcquireIntangibleAssetsIncludingClosing", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/IntangibleAssetsDetails" ], "xbrltype": "sharesItemType" }, "pmedf_SharesIssuedToAcquireIntangibleAssetsValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent the shares issued to acquire intangible assets, value per share.", "label": "Shares issued to acquire intangible assets, value per share" } } }, "localname": "SharesIssuedToAcquireIntangibleAssetsValuePerShare", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetails" ], "xbrltype": "perShareItemType" }, "pmedf_StockOptionsGrantAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by stock options granted under share-based payment arrangement.", "label": "Stock Options Grant [Axis]" } } }, "localname": "StockOptionsGrantAxis", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals", "http://predictmedix.com/role/StockbasedCompensationDetails", "http://predictmedix.com/role/StockbasedCompensationTables" ], "xbrltype": "stringItemType" }, "pmedf_StockOptionsGrantDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock options granted under share-based payment arrangement.", "label": "Stock Options Grant [Domain]" } } }, "localname": "StockOptionsGrantDomain", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals", "http://predictmedix.com/role/StockbasedCompensationDetails", "http://predictmedix.com/role/StockbasedCompensationTables" ], "xbrltype": "domainItemType" }, "pmedf_StockOptionsGrantEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Options Grant Eight [Member]", "label": "Stock Options Grant Eight [Member]", "verboseLabel": "Stock Options Granted on March 23, 2021 [Member]" } } }, "localname": "StockOptionsGrantEightMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals", "http://predictmedix.com/role/StockbasedCompensationDetails", "http://predictmedix.com/role/StockbasedCompensationTables" ], "xbrltype": "domainItemType" }, "pmedf_StockOptionsGrantFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fifth grant of stock options under share-based payment arrangement.", "label": "Stock Options Grant Five [Member]", "verboseLabel": "Stock Options Granted on September 10, 2020 [Member]" } } }, "localname": "StockOptionsGrantFiveMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals", "http://predictmedix.com/role/StockbasedCompensationDetails", "http://predictmedix.com/role/StockbasedCompensationTables" ], "xbrltype": "domainItemType" }, "pmedf_StockOptionsGrantFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fourth grant of stock options under share-based payment arrangement.", "label": "Stock Options Grant Four [Member]", "verboseLabel": "Stock Options Granted on July 17, 2020 [Member]" } } }, "localname": "StockOptionsGrantFourMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals", "http://predictmedix.com/role/StockbasedCompensationDetails", "http://predictmedix.com/role/StockbasedCompensationTables" ], "xbrltype": "domainItemType" }, "pmedf_StockOptionsGrantNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Options Grant Nine [Member]", "label": "Stock Options Grant Nine [Member]", "verboseLabel": "Stock Options Granted on June 9, 2021 [Member]" } } }, "localname": "StockOptionsGrantNineMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals", "http://predictmedix.com/role/StockbasedCompensationDetails", "http://predictmedix.com/role/StockbasedCompensationTables" ], "xbrltype": "domainItemType" }, "pmedf_StockOptionsGrantOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First grant of stock options under share-based payment arrangement.", "label": "Stock Options Grant One [Member]", "verboseLabel": "Stock Options Granted in October 2018 [Member]" } } }, "localname": "StockOptionsGrantOneMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals", "http://predictmedix.com/role/StockbasedCompensationDetails", "http://predictmedix.com/role/StockbasedCompensationTables" ], "xbrltype": "domainItemType" }, "pmedf_StockOptionsGrantSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Seventh grant of stock options under share-based payment arrangement.", "label": "Stock Options Grant Seven [Member]", "verboseLabel": "Stock Options Granted on September 21, 2020 [Member]" } } }, "localname": "StockOptionsGrantSevenMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals", "http://predictmedix.com/role/StockbasedCompensationDetails", "http://predictmedix.com/role/StockbasedCompensationTables" ], "xbrltype": "domainItemType" }, "pmedf_StockOptionsGrantSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sixth grant of stock options under share-based payment arrangement.", "label": "Stock Options Grant Six [Member]", "verboseLabel": "Stock Options Granted on September 17, 2020 [Member]" } } }, "localname": "StockOptionsGrantSixMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals", "http://predictmedix.com/role/StockbasedCompensationDetails", "http://predictmedix.com/role/StockbasedCompensationTables" ], "xbrltype": "domainItemType" }, "pmedf_StockOptionsGrantTenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Options Grant Ten [Member]", "label": "Stock Options Grant Ten [Member]", "verboseLabel": "Stock Options Granted on July 30, 2021 [Member]" } } }, "localname": "StockOptionsGrantTenMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals", "http://predictmedix.com/role/StockbasedCompensationDetails", "http://predictmedix.com/role/StockbasedCompensationTables" ], "xbrltype": "domainItemType" }, "pmedf_StockOptionsGrantThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third grant of stock options under share-based payment arrangement.", "label": "Stock Options Grant Three [Member]", "verboseLabel": "Stock Options Granted on April 6, 2020 [Member]" } } }, "localname": "StockOptionsGrantThreeMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals", "http://predictmedix.com/role/StockbasedCompensationDetails", "http://predictmedix.com/role/StockbasedCompensationTables" ], "xbrltype": "domainItemType" }, "pmedf_StockOptionsGrantTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second grant of stock options under share-based payment arrangement.", "label": "Stock Options Grant Two [Member]", "verboseLabel": "Stock Options Granted in November 2018 [Member]" } } }, "localname": "StockOptionsGrantTwoMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals", "http://predictmedix.com/role/StockbasedCompensationDetails", "http://predictmedix.com/role/StockbasedCompensationTables" ], "xbrltype": "domainItemType" }, "pmedf_StudyOnDetectionTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for the study on detection technology.", "label": "Study On Detection Technology [Member]", "terseLabel": "Study on detection technology [Member]" } } }, "localname": "StudyOnDetectionTechnologyMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/PrepaidExpensesDetailTextuals" ], "xbrltype": "domainItemType" }, "pmedf_SubsidiariesOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for entities that are controlled by another entity.", "label": "Subsidiaries One [Member]", "terseLabel": "CannIP Holdings Inc. [Member]" } } }, "localname": "SubsidiariesOneMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/BasisOfPresentationAndGoingConcernDetails", "http://predictmedix.com/role/OrganizationAndNatureOfOperationsDetailTextuals" ], "xbrltype": "domainItemType" }, "pmedf_SubsidiariesThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for subsidiaries three.", "label": "Subsidiaries Three [Member]", "terseLabel": "Local Jamaican business partners [Member]" } } }, "localname": "SubsidiariesThreeMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/OrganizationAndNatureOfOperationsDetailTextuals" ], "xbrltype": "domainItemType" }, "pmedf_SubsidiariesTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for subsidiaries two.", "label": "Subsidiaries Two [Member]", "terseLabel": "Cultivar JA Limited [Member]" } } }, "localname": "SubsidiariesTwoMember", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/BasisOfPresentationAndGoingConcernDetails", "http://predictmedix.com/role/CapitalStockDetailTextuals", "http://predictmedix.com/role/OrganizationAndNatureOfOperationsDetailTextuals", "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedDetailTextuals", "http://predictmedix.com/role/SaleOfInterestInCultivarJALimitedDetails" ], "xbrltype": "domainItemType" }, "pmedf_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "verboseLabel": "Supplemental cash flow information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "pmedf_TaxEffectOfChangeDueToAcquisitionTaxRatesAndOther": { "auth_ref": [], "calculation": { "http://predictmedix.com/role/IncomeTaxesDetails": { "order": 10.0, "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "It represents tax effect change due to acquisition tax rates and other.", "label": "Tax Effect Of Change Due To Acquisition Tax Rates And Other", "verboseLabel": "Change due to acquisition, tax rates, and other" } } }, "localname": "TaxEffectOfChangeDueToAcquisitionTaxRatesAndOther", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "pmedf_TaxEffectOfChangeInUnrecognizedDeductibleTemporaryDifferences": { "auth_ref": [], "calculation": { "http://predictmedix.com/role/IncomeTaxesDetails": { "order": 50.0, "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "It represents tax effect of change in unrecognized deductible temporary differences.", "label": "Tax Effect Of Change In Unrecognized Deductible Temporary Differences", "verboseLabel": "Change in unrecognized deductible temporary differences" } } }, "localname": "TaxEffectOfChangeInUnrecognizedDeductibleTemporaryDifferences", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "pmedf_TaxEffectOfExpiredNonCapitalLosses": { "auth_ref": [], "calculation": { "http://predictmedix.com/role/IncomeTaxesDetails": { "order": 30.0, "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "It represents tax effect of expired non-capital losses.", "label": "Tax Effect Of Expired Non Capital Losses", "verboseLabel": "Expired non-capital losses" } } }, "localname": "TaxEffectOfExpiredNonCapitalLosses", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "pmedf_TaxEffectOfShareIssuanceCosts": { "auth_ref": [], "calculation": { "http://predictmedix.com/role/IncomeTaxesDetails": { "order": 40.0, "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "It represents tax effect of share issuance costs.", "label": "Tax Effect Of Share Issuance Costs", "verboseLabel": "Share issuance costs" } } }, "localname": "TaxEffectOfShareIssuanceCosts", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "pmedf_TermOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term of warrants.", "label": "Term Of Warrants", "terseLabel": "Term of warrants" } } }, "localname": "TermOfWarrants", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "durationItemType" }, "pmedf_TransferAgentAndFilingFees": { "auth_ref": [], "calculation": { "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 0.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of transfer agent and filing fees.", "label": "Transfer Agent And Filing Fees", "terseLabel": "Transfer agent and filing fees" } } }, "localname": "TransferAgentAndFilingFees", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "pmedf_UnitsIssuedPricePerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Units Issued price per unit.", "label": "Units Issued Price Per Unit", "terseLabel": "Units issued price per unit" } } }, "localname": "UnitsIssuedPricePerUnit", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetailTextuals" ], "xbrltype": "perShareItemType" }, "pmedf_UnrecognizedDeferredTaxAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "It represents unrecognized deferred tax assets.", "label": "Unrecognized Deferred Tax Assets", "negatedLabel": "Less: Unrecognized deferred tax assets" } } }, "localname": "UnrecognizedDeferredTaxAssets", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "pmedf_UnvestedStockBasedCompensationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the value of unvested stock based compensation expense.", "label": "Unvested Stock Based Compensation Expense", "verboseLabel": "Unvested stock-based compensation expense" } } }, "localname": "UnvestedStockBasedCompensationExpense", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals", "http://predictmedix.com/role/StockbasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "pmedf_ValueOfSharesIssuedToAcquireIntangibleAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represent the value of shares issued to acquire intangible assets.", "label": "Value Of Shares Issued To Acquire Intangible Assets", "terseLabel": "Issued shares (50,000 shares issued at $1.06/share)" } } }, "localname": "ValueOfSharesIssuedToAcquireIntangibleAssets", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "pmedf_VehicleExpenseKeyManagementPersonnel": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the vehicle expense paid to key management personnel.", "label": "Vehicle Expense Key Management Personnel", "terseLabel": "Vehicle expense" } } }, "localname": "VehicleExpenseKeyManagementPersonnel", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "pmedf_VestingScheduleAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by vesting schedule of options under share-based payment arrangement.", "label": "Vesting Schedule [Axis]" } } }, "localname": "VestingScheduleAxis", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals" ], "xbrltype": "stringItemType" }, "pmedf_VestingScheduleDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vesting schedule of options under share-based payment arrangement.", "label": "Vesting Schedule [Domain]" } } }, "localname": "VestingScheduleDomain", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/StockbasedCompensationDetailTextuals" ], "xbrltype": "domainItemType" }, "pmedf_WeightedAverageRemainingContractualLifeOfOutstandingWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average remaining contractual life of outstanding warrants.", "label": "Weighted Average Remaining Contractual Life Of Outstanding Warrants", "terseLabel": "Remaining Life (Years)" } } }, "localname": "WeightedAverageRemainingContractualLifeOfOutstandingWarrants", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/CapitalStockDetails1" ], "xbrltype": "durationItemType" }, "pmedf_WorkingCapital": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of working capital.", "label": "Working Capital", "terseLabel": "Working capital" } } }, "localname": "WorkingCapital", "nsuri": "http://predictmedix.com/20220131", "presentation": [ "http://predictmedix.com/role/BasisOfPresentationAndGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]", "terseLabel": "CEO [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://predictmedix.com/role/CommitmentsAndContingenciesDetailTextuals", "http://predictmedix.com/role/RelatedPartyTransactionsDetailTextuals", "http://predictmedix.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "srt_ChiefFinancialOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Chief Financial Officer [Member]", "terseLabel": "CFO [Member]" } } }, "localname": "ChiefFinancialOfficerMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://predictmedix.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "srt_ChiefOperatingOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Chief Operating Officer [Member]", "terseLabel": "COO [Member]" } } }, "localname": "ChiefOperatingOfficerMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://predictmedix.com/role/CommitmentsAndContingenciesDetailTextuals", "http://predictmedix.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "srt_DirectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Director [Member]", "terseLabel": "A prior director [Member]" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://predictmedix.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://predictmedix.com/role/BusinessSegmentAndConcentrationDetailTextuals", "http://predictmedix.com/role/FinancialInstrumentsDetailTextuals" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://predictmedix.com/role/BusinessSegmentAndConcentrationDetailTextuals" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://predictmedix.com/role/BusinessSegmentAndConcentrationDetailTextuals" ], "xbrltype": "stringItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "10", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_10_e&doctype=Standard", "URIDate": "2021-03-24" }, "r1": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "102", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_102&doctype=Standard", "URIDate": "2021-03-24" }, "r10": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "117", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117&doctype=Standard", "URIDate": "2021-03-24" }, "r100": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "50", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2021-03-24" }, "r101": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "1", "Paragraph": "24", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2021-03-24" }, "r102": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "1", "Paragraph": "24", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2021-03-24" }, "r103": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "1", "Paragraph": "32", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2021-03-24" }, "r104": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "1", "Paragraph": "32", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r105": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "12", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_c&doctype=Standard", "URIDate": "2021-03-24" }, "r106": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "12", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_e&doctype=Standard", "URIDate": "2021-03-24" }, "r107": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "19B", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_19B_c&doctype=Standard", "URIDate": "2021-03-24" }, "r108": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B10", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r109": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r11": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "134", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_134&doctype=Standard", "URIDate": "2021-03-24" }, "r110": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r111": { "Clause": "v", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r112": { "Clause": "vii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_vii&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r113": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r114": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_f&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r115": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r116": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B4", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r117": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2021-03-24" }, "r118": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2021-03-24" }, "r119": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2021-03-24" }, "r12": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_a&doctype=Standard", "URIDate": "2021-03-24" }, "r120": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "47", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2021-03-24" }, "r121": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_a&doctype=Standard", "URIDate": "2021-03-24" }, "r122": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_b&doctype=Standard", "URIDate": "2021-03-24" }, "r123": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "j", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_j&doctype=Standard", "URIDate": "2021-03-24" }, "r124": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53&doctype=Standard", "URIDate": "2021-03-24" }, "r125": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "59", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_59&doctype=Standard", "URIDate": "2021-03-24" }, "r126": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI", "URIDate": "2021-03-24" }, "r127": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Section": "Presentation", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI", "URIDate": "2021-03-24" }, "r128": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "44", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_44&doctype=Standard", "URIDate": "2021-03-24" }, "r129": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_a&doctype=Standard", "URIDate": "2021-03-24" }, "r13": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_c&doctype=Standard", "URIDate": "2021-03-24" }, "r130": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_i&doctype=Standard", "URIDate": "2021-03-24" }, "r131": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r132": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_iv&doctype=Standard", "URIDate": "2021-03-24" }, "r133": { "Clause": "v", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_v&doctype=Standard", "URIDate": "2021-03-24" }, "r134": { "Clause": "vi", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_vi&doctype=Standard", "URIDate": "2021-03-24" }, "r135": { "Clause": "vii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_vii&doctype=Standard", "URIDate": "2021-03-24" }, "r136": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b&doctype=Standard", "URIDate": "2021-03-24" }, "r137": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2021-03-24" }, "r138": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard", "URIDate": "2021-03-24" }, "r139": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "47", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_a_i&doctype=Standard", "URIDate": "2021-03-24" }, "r14": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "i", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_i&doctype=Standard", "URIDate": "2021-03-24" }, "r140": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "47", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2021-03-24" }, "r141": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f_iv&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r142": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r143": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "i", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r144": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r145": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B67", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r146": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "IE72", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_IE72&doctype=Illustrative%20Examples", "URIDate": "2021-03-24" }, "r147": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Section": "Disclosures", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS03_g59-63__IFRS03_g59-63_TI", "URIDate": "2021-03-24" }, "r148": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Section": "Disclosures application of paragraphs 59 and 61", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&doctype=Appendix&subtype=B&dita_xref=IFRS03_gB64-B67_TI", "URIDate": "2021-03-24" }, "r149": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "5", "Paragraph": "33", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2021-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2021-03-24" }, "r15": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "k", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_k&doctype=Standard", "URIDate": "2021-03-24" }, "r150": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "5", "Paragraph": "33", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2021-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2021-03-24" }, "r151": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "5", "Paragraph": "33", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2021-en-r&anchor=para_33_b_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r152": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "5", "Paragraph": "33", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2021-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2021-03-24" }, "r153": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "5", "Section": "Presentation and disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS05_g30-42_TI", "URIDate": "2021-03-24" }, "r154": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "21C", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_21C&doctype=Standard", "URIDate": "2021-03-24" }, "r155": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "31", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_31&doctype=Standard", "URIDate": "2021-03-24" }, "r156": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "32", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_32&doctype=Standard", "URIDate": "2021-03-24" }, "r157": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "33", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_33&doctype=Standard", "URIDate": "2021-03-24" }, "r158": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "34", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard", "URIDate": "2021-03-24" }, "r159": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "35H", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35H&doctype=Standard", "URIDate": "2021-03-24" }, "r16": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "o", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_o&doctype=Standard", "URIDate": "2021-03-24" }, "r160": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "35I", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35I&doctype=Standard", "URIDate": "2021-03-24" }, "r161": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "35K", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35K&doctype=Standard", "URIDate": "2021-03-24" }, "r162": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "35M", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2021-03-24" }, "r163": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "35N", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35N&doctype=Standard", "URIDate": "2021-03-24" }, "r164": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "7", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard", "URIDate": "2021-03-24" }, "r165": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Section": "Scope", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI", "URIDate": "2021-03-24" }, "r166": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_a&doctype=Standard", "URIDate": "2021-03-24" }, "r167": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_d&doctype=Standard", "URIDate": "2021-03-24" }, "r168": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "h", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2021-03-24" }, "r169": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "23", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23&doctype=Standard", "URIDate": "2021-03-24" }, "r17": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "55", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_55&doctype=Standard", "URIDate": "2021-03-24" }, "r170": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_a&doctype=Standard", "URIDate": "2021-03-24" }, "r171": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2021-03-24" }, "r172": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2021-03-24" }, "r173": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2021-03-24" }, "r174": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_e&doctype=Standard", "URIDate": "2021-03-24" }, "r175": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "32", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_32&doctype=Standard", "URIDate": "2021-03-24" }, "r176": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "33", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2021-03-24" }, "r177": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "34", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard", "URIDate": "2021-03-24" }, "r178": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "113", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2021-03-24" }, "r179": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "124", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_124&doctype=Standard", "URIDate": "2021-03-24" }, "r18": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "56", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_56&doctype=Standard", "URIDate": "2021-03-24" }, "r180": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "125", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_125&doctype=Standard", "URIDate": "2021-03-24" }, "r181": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "127", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_127&doctype=Standard", "URIDate": "2021-03-24" }, "r182": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "128", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_128_a&doctype=Standard", "URIDate": "2021-03-24" }, "r183": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective on first application of IFRS 9", "Number": "4", "Paragraph": "39L", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39L_e&doctype=Standard", "URIDate": "2021-03-24" }, "r184": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "37", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_b&doctype=Standard&book=b", "URIDate": "2021-03-24" }, "r185": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "IG29", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29_a&doctype=Implementation%20Guidance&book=b", "URIDate": "2021-03-24" }, "r186": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "IG29", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29&doctype=Implementation%20Guidance&book=b", "URIDate": "2021-03-24" }, "r187": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r188": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r189": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r19": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "66", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard", "URIDate": "2021-03-24" }, "r190": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r191": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r192": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r193": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r194": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r195": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r196": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r197": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "103", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_103&doctype=Standard", "URIDate": "2021-03-24" }, "r20": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "68", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_68&doctype=Standard", "URIDate": "2021-03-24" }, "r21": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "69", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_69&doctype=Standard", "URIDate": "2021-03-24" }, "r22": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2021-03-24" }, "r23": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2021-03-24" }, "r24": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "78", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78&doctype=Standard", "URIDate": "2021-03-24" }, "r25": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_iv&doctype=Standard", "URIDate": "2021-03-24" }, "r26": { "Clause": "vi", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_vi&doctype=Standard", "URIDate": "2021-03-24" }, "r27": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2021-03-24" }, "r28": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "81A", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_a&doctype=Standard", "URIDate": "2021-03-24" }, "r29": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "81B", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81B_a_i&doctype=Standard", "URIDate": "2021-03-24" }, "r3": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_i&doctype=Standard", "URIDate": "2021-03-24" }, "r30": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "81B", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81B_a_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r31": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "82", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_a&doctype=Standard", "URIDate": "2021-03-24" }, "r32": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "82", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_d&doctype=Standard", "URIDate": "2021-03-24" }, "r33": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "82", "Subparagraph": "ea", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_ea&doctype=Standard", "URIDate": "2021-03-24" }, "r34": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "85", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_85&doctype=Standard", "URIDate": "2021-03-24" }, "r35": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "98", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_98_e&doctype=Standard", "URIDate": "2021-03-24" }, "r36": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "99", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_99&doctype=Standard", "URIDate": "2021-03-24" }, "r37": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "IG6", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2021-03-24" }, "r38": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "79", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_79&doctype=Standard", "URIDate": "2021-03-24" }, "r39": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2021-03-24" }, "r4": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r40": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r41": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_e&doctype=Standard", "URIDate": "2021-03-24" }, "r42": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g_i&doctype=Standard", "URIDate": "2021-03-24" }, "r43": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g&doctype=Standard", "URIDate": "2021-03-24" }, "r44": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI", "URIDate": "2021-03-24" }, "r45": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "37", "Subparagraph": "h", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37_h&doctype=Standard", "URIDate": "2021-03-24" }, "r46": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "37", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37&doctype=Standard", "URIDate": "2021-03-24" }, "r47": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_c&doctype=Standard", "URIDate": "2021-03-24" }, "r48": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_d&doctype=Standard", "URIDate": "2021-03-24" }, "r49": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_i&doctype=Standard", "URIDate": "2021-03-24" }, "r5": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2021-03-24" }, "r50": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r51": { "Clause": "vii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_vii&doctype=Standard", "URIDate": "2021-03-24" }, "r52": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2021-03-24" }, "r53": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73&doctype=Standard", "URIDate": "2021-03-24" }, "r54": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "75", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_75_a&doctype=Standard", "URIDate": "2021-03-24" }, "r55": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "75", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_75_b&doctype=Standard", "URIDate": "2021-03-24" }, "r56": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI", "URIDate": "2021-03-24" }, "r57": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "9", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_9&doctype=Standard", "URIDate": "2021-03-24" }, "r58": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "17", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17&doctype=Standard", "URIDate": "2021-03-24" }, "r59": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "18", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2021-03-24" }, "r6": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106&doctype=Standard", "URIDate": "2021-03-24" }, "r60": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "19", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19_c&doctype=Standard", "URIDate": "2021-03-24" }, "r61": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "19", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19&doctype=Standard", "URIDate": "2021-03-24" }, "r62": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "20", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_20&doctype=Standard", "URIDate": "2021-03-24" }, "r63": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Section": "Disclosures", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI", "URIDate": "2021-03-24" }, "r64": { "Clause": "vi", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "26", "Paragraph": "35", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_vi&doctype=Standard", "URIDate": "2021-03-24" }, "r65": { "Clause": "viii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "26", "Paragraph": "35", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2021-03-24" }, "r66": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r67": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2021-03-24" }, "r68": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r69": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2021-03-24" }, "r7": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "108", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_108&doctype=Standard", "URIDate": "2021-03-24" }, "r70": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "33", "Paragraph": "66", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard", "URIDate": "2021-03-24" }, "r71": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "33", "Paragraph": "67", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_67&doctype=Standard", "URIDate": "2021-03-24" }, "r72": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "33", "Paragraph": "70", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2021-03-24" }, "r73": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "127", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_127&doctype=Standard", "URIDate": "2021-03-24" }, "r74": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_a&doctype=Standard", "URIDate": "2021-03-24" }, "r75": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_b&doctype=Standard", "URIDate": "2021-03-24" }, "r76": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_c&doctype=Standard", "URIDate": "2021-03-24" }, "r77": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_i&doctype=Standard", "URIDate": "2021-03-24" }, "r78": { "Clause": "vi", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_vi&doctype=Standard", "URIDate": "2021-03-24" }, "r79": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2021-03-24" }, "r8": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "112", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_112_c&doctype=Standard", "URIDate": "2021-03-24" }, "r80": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118&doctype=Standard", "URIDate": "2021-03-24" }, "r81": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "126", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_126&doctype=Standard", "URIDate": "2021-03-24" }, "r82": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS38_g118-128_TI", "URIDate": "2021-03-24" }, "r83": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "40", "Paragraph": "76", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_76&doctype=Standard", "URIDate": "2021-03-24" }, "r84": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "40", "Paragraph": "79", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_79_c&doctype=Standard", "URIDate": "2021-03-24" }, "r85": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "40", "Paragraph": "79", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_79_d&doctype=Standard", "URIDate": "2021-03-24" }, "r86": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "41", "Paragraph": "50", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_50&doctype=Standard", "URIDate": "2021-03-24" }, "r87": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "41", "Paragraph": "54", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2021-03-24" }, "r88": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "10", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_10&doctype=Standard", "URIDate": "2021-03-24" }, "r89": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "16", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2021-03-24" }, "r9": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "117", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117_b&doctype=Standard", "URIDate": "2021-03-24" }, "r90": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "17", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2021-03-24" }, "r91": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "17", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2021-03-24" }, "r92": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "17", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17&doctype=Standard", "URIDate": "2021-03-24" }, "r93": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "18", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2021-03-24" }, "r94": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "20", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2021-03-24" }, "r95": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "20", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2021-03-24" }, "r96": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "20", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20&doctype=Standard", "URIDate": "2021-03-24" }, "r97": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "35", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35&doctype=Standard", "URIDate": "2021-03-24" }, "r98": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "45", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard", "URIDate": "2021-03-24" }, "r99": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "46", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_46&doctype=Standard", "URIDate": "2021-03-24" } }, "version": "2.1" }